| Year |
Citation |
Score |
| 2024 |
Piga M, Tselios K, Viveiros L, Chessa E, Neves A, Urowitz MB, Isenberg D. Clinical patterns of disease: From early systemic lupus erythematosus to late-onset disease. Best Practice & Research. Clinical Rheumatology. 101938. PMID 38388232 DOI: 10.1016/j.berh.2024.101938 |
0.345 |
|
| 2024 |
Whittall-Garcia LP, Naderinabi F, Gladman DD, Urowitz M, Touma Z, Konvalinka A, Wither J. Circulating neutrophil extracellular trap remnants as a biomarker to predict outcomes in lupus nephritis. Lupus Science & Medicine. 11. PMID 38177067 DOI: 10.1136/lupus-2023-001038 |
0.49 |
|
| 2023 |
Manion K, Muñoz-Grajales C, Kim M, Atenafu E, Faheem Z, Gladman DD, Urowitz M, Touma Z, Wither JE. Different Immunologic Profiles are Associated with Distinct Clinical Phenotypes in Longitudinally Followed Systemic Lupus Erythematosus Patients. Arthritis & Rheumatology (Hoboken, N.J.). PMID 38073017 DOI: 10.1002/art.42776 |
0.633 |
|
| 2023 |
Whittall-Garcia L, Gladman DD, Urowitz MB, Touma Z, Johnson SR. Correspondence on "relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus" by Chi Chiu Mok et al. Lupus. 32: 810-811. PMID 37125665 DOI: 10.1177/09612033231171365 |
0.513 |
|
| 2023 |
Tang TS, Liao F, Webber D, Gold N, Cao J, Dominguez D, Gladman D, Knight A, Levy DM, Ng L, Paterson AD, Touma Z, Urowitz MB, Wither J, Silverman ED, et al. Genetics of longitudinal kidney function in children and adults with systemic lupus erythematosus. Rheumatology (Oxford, England). PMID 36916720 DOI: 10.1093/rheumatology/kead119 |
0.553 |
|
| 2023 |
Webber D, Cao J, Dominguez D, Gladman DD, Knight A, Levy DM, Liao F, Ng L, Paterson AD, Touma Z, Wither J, Urowitz M, Silverman ED, Hiraki LT. Genetics of Osteonecrosis in Children and Adults with Systemic Lupus Erythematosus. Rheumatology (Oxford, England). PMID 36651668 DOI: 10.1093/rheumatology/kead016 |
0.522 |
|
| 2022 |
Johnson SR, Martinez JPD, Whittall-Garcia L, Urowitz MB, Gladman DD, Touma Z. Evaluating the threshold score for classification of systemic lupus erythematosus using the EULAR/ACR criteria. The Journal of Rheumatology. PMID 36319012 DOI: 10.3899/jrheum.220100 |
0.568 |
|
| 2022 |
Alhammadi NA, Gladman DD, Su J, Urowitz MB. Isolated Neutropenia in Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 36243416 DOI: 10.3899/jrheum.220373 |
0.349 |
|
| 2022 |
Whittall-Garcia L, Gladman DD, Urowitz MB, Su J, Touma Z, Johnson SR. The new EULAR/ACR 2019 SLE classification criteria: A predictor of long-term outcomes. Seminars in Arthritis and Rheumatism. 57: 152103. PMID 36219896 DOI: 10.1016/j.semarthrit.2022.152103 |
0.526 |
|
| 2022 |
Ugarte-Gil MF, Hanly J, Urowitz M, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, et al. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Annals of the Rheumatic Diseases. PMID 35944946 DOI: 10.1136/ard-2022-222487 |
0.396 |
|
| 2022 |
Papachristos DA, Gladman DD, Su J, Urowitz MB. Outcomes following antimalarial withdrawal in patients with quiescent systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 55: 152046. PMID 35716465 DOI: 10.1016/j.semarthrit.2022.152046 |
0.318 |
|
| 2022 |
Whittall-Garcia L, Goliad K, Kim M, Bonilla D, Gladman D, Urowitz M, Fortin PR, Atenafu EG, Touma Z, Wither J. Identification and Validation of a Urinary Biomarker Panel to Accurately Diagnose and Predict Response to Therapy in Lupus Nephritis. Frontiers in Immunology. 13: 889931. PMID 35711439 DOI: 10.3389/fimmu.2022.889931 |
0.529 |
|
| 2022 |
Urowitz MB, Aranow C, Asukai Y, Bass DL, Bruce IN, Chauhan D, Dall'Era M, Furie R, Fox NL, Gilbride JA, Hammer A, Ginzler EM, Gonzalez-Rivera T, Levy RA, Merrill JT, et al. Impact of belimumab on organ damage in systemic lupus erythematosus. Arthritis Care & Research. PMID 35439360 DOI: 10.1002/acr.24901 |
0.333 |
|
| 2022 |
Choi MY, Clarke AE, Urowitz M, Hanly J, St-Pierre Y, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Wallace DJ, Isenberg D, Rahman A, Merrill JT, Fortin PR, et al. Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Annals of the Rheumatic Diseases. PMID 35338033 DOI: 10.1136/annrheumdis-2022-222168 |
0.333 |
|
| 2021 |
Johnson SR, Gladman DD, Brunner HI, Isenberg D, Clarke AE, Barber MRW, Arnaud L, Fortin PR, Mosca M, Voskuyl A, Manzi S, Aranow C, Askanase A, Alarcón GS, Bae SC, ... ... Urowitz M, et al. Evaluating the construct of damage in systemic lupus erythematosus. Arthritis Care & Research. PMID 34962100 DOI: 10.1002/acr.24849 |
0.595 |
|
| 2021 |
Almeida-Brasil CC, Hanly JG, Urowitz M, Clarke AE, Ruiz-Irastorza G, Gordon C, Ramsey-Goldman R, Petri M, Ginzler EM, Wallace DJ, Bae SC, Romero-Diaz J, Dooley MA, Peschken C, Isenberg D, et al. Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Annals of the Rheumatic Diseases. PMID 34911705 DOI: 10.1136/annrheumdis-2021-221295 |
0.37 |
|
| 2021 |
Whittall-Garcia L, Gladman DD, Urowitz M, Su J, Touma Z, Johnson SR. Response to: Correspondence on "New EULAR/ACR 2019 SLE classification criteria: defining ominosity in SLE" by Whittall Garcia . Annals of the Rheumatic Diseases. PMID 34344704 DOI: 10.1136/annrheumdis-2021-221014 |
0.539 |
|
| 2021 |
Tselios K, Gladman DD, Su J, Urowitz MB. Gradual Glucocorticosteroid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus Erythematosus. Acr Open Rheumatology. PMID 34245233 DOI: 10.1002/acr2.11267 |
0.399 |
|
| 2021 |
Sivakumaran J, Harvey P, Omar A, Tayer-Shifman O, Urowitz MB, Gladman DD, Anderson N, Su J, Touma Z. Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus. Lupus Science & Medicine. 8. PMID 34045359 DOI: 10.1136/lupus-2020-000448 |
0.562 |
|
| 2021 |
Furie RA, Bruce IN, Dörner T, Leon MG, Leszczyński P, Urowitz M, Haier B, Jimenez T, Brittain C, Liu J, Barbey C, Stach C. Phase 2, Randomized, Placebo-Controlled Trial of Dapirolizumab Pegol in Patients with Moderate-to-Severe Active Systemic Lupus Erythematosus. Rheumatology (Oxford, England). PMID 33956056 DOI: 10.1093/rheumatology/keab381 |
0.319 |
|
| 2021 |
Aringer M, Brinks R, Dörner T, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, ... ... Urowitz M, et al. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Annals of the Rheumatic Diseases. PMID 33568386 DOI: 10.1136/annrheumdis-2020-219373 |
0.546 |
|
| 2021 |
Whittall Garcia LP, Gladman DD, Urowitz M, Touma Z, Su J, Johnson SR. New EULAR/ACR 2019 SLE Classification Criteria: defining ominosity in SLE. Annals of the Rheumatic Diseases. PMID 33452003 DOI: 10.1136/annrheumdis-2020-218670 |
0.614 |
|
| 2021 |
Mai L, Asaduzzaman A, Noamani B, Fortin PR, Gladman DD, Touma Z, Urowitz MB, Wither J. The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus. Arthritis Research & Therapy. 23: 29. PMID 33451338 DOI: 10.1186/s13075-021-02414-0 |
0.604 |
|
| 2020 |
Tselios K, Gladman DD, Taheri C, Su J, Urowitz MB. Factors Associated with Rapid Progression to End Stage Kidney Disease in Lupus Nephritis. The Journal of Rheumatology. PMID 33259331 DOI: 10.3899/Jrheum.200161 |
0.388 |
|
| 2020 |
Johnson SR, Brinks R, Costenbader KH, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, ... ... Urowitz M, et al. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. Annals of the Rheumatic Diseases. PMID 32816709 DOI: 10.1136/Annrheumdis-2020-217162 |
0.66 |
|
| 2020 |
Almaghlouth I, Pullenayegum E, Gladman DD, Urowitz MB, Johnson SR. Propensity Score Methods in Rare Disease. A Demonstration Using Observational Data in Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 32611674 DOI: 10.3899/Jrheum.200254 |
0.448 |
|
| 2020 |
Mendel A, Bernatsky S, Askanase A, Bae SC, Clarke AE, Costedoat-Chalumeau N, Gladman DD, Gordon C, Hanly J, Jacobsen S, Kalunian K, Mak A, Mosca M, Pons-Estel BA, Ruiz-Irastorza G, ... Urowitz M, et al. Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics. Annals of the Rheumatic Diseases. PMID 32586918 DOI: 10.1136/Annrheumdis-2020-218164 |
0.479 |
|
| 2020 |
Urowitz MB, Gladman DD, Farewell V, Su J, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg D, Rahman A, et al. Accrual of atherosclerotic vascular events in a multicentre inception SLE cohort. Arthritis & Rheumatology (Hoboken, N.J.). PMID 32515554 DOI: 10.1002/Art.41392 |
0.395 |
|
| 2020 |
Petri M, Goldman DW, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace D, Nived O, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke AE, ... ... Urowitz M, et al. A Comparison of 2019 EULAR/ACR SLE Classification Criteria with Two Sets of Earlier SLE Classification Criteria. Arthritis Care & Research. PMID 32433832 DOI: 10.1002/Acr.24263 |
0.389 |
|
| 2020 |
Touma Z, Gladman DD, Zandy M, Su J, Anderson N, Urowitz MB. Identifying a response for the systemic lupus erythematosus disease activity glucocorticoid index (SLEDAI-2KG). Arthritis Care & Research. PMID 32433815 DOI: 10.1002/Acr.24261 |
0.642 |
|
| 2020 |
Tselios K, Gladman DD, Su J, Urowitz MB. Advanced Chronic Kidney Disease in Lupus Nephritis: Is Dialysis Inevitable? The Journal of Rheumatology. PMID 32238519 DOI: 10.3899/Jrheum.191064 |
0.311 |
|
| 2020 |
Urowitz MB, Gladman DD, Ibañez D, Su J, Mursleen S, Sayani A, Alfonso J, Terres R, Iczkovitz S. Impact of disease activity on organ damage progression in systemic lupus erythematosus: University of Toronto Lupus Clinic Cohort. The Journal of Rheumatology. PMID 32238510 DOI: 10.3899/Jrheum.190259 |
0.481 |
|
| 2020 |
Tselios K, Gladman DD, Su J, Urowitz M. Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus. Annals of the Rheumatic Diseases. PMID 32156706 DOI: 10.1136/Annrheumdis-2019-216764 |
0.383 |
|
| 2020 |
Hanly JG, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, et al. Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach. Annals of the Rheumatic Diseases. PMID 31915121 DOI: 10.1136/Annrheumdis-2019-216150 |
0.41 |
|
| 2020 |
Urowitz M, Bonfá E, Pons-Estel B. 16 Management of cardiovascular risk in SLE Lupus Science & Medicine. 7. DOI: 10.1136/Lupus-2020-La.16 |
0.368 |
|
| 2020 |
Aringer M, Brinks R, Costenbader K, Boumpas D, Daikh D, Jayne D, Kamen DL, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Diamond B, Jacobsen S, McCune WJ, Ruiz-Irastorza G, ... ... Urowitz M, et al. O8 Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematosus in men, ethnicities, and early disease Lupus Science & Medicine. 7. DOI: 10.1136/Lupus-2020-Eurolupus.21 |
0.619 |
|
| 2020 |
Johnson S, Brinks R, Costenbader K, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas D, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, ... ... Urowitz MB, et al. Thu0271 Performance Of The Eular/Acr 2019 Classification Criteria For Systemic Lupus Erythematosus In Early Disease, Across Sexes And Ethnicities Annals of the Rheumatic Diseases. 79: 362-362. DOI: 10.1136/Annrheumdis-2020-Eular.2324 |
0.57 |
|
| 2019 |
Hanneman K, Alberdi HV, Karur GR, Tselios K, Harvey PJ, Gladman DD, Akhtari S, Osuntokun T, Wald RM, Thavendiranathan P, Butany J, Urowitz MB. Antimalarial-Induced Cardiomyopathy Resembles Fabry Disease on Cardiac MRI. Jacc. Cardiovascular Imaging. PMID 31734202 DOI: 10.1016/J.Jcmg.2019.09.014 |
0.397 |
|
| 2019 |
Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin PR, Gladman DD, ... Urowitz MB, et al. Prediction of damage accrual in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI). Arthritis & Rheumatology (Hoboken, N.J.). PMID 31631584 DOI: 10.1002/Art.41144 |
0.442 |
|
| 2019 |
Enocsson H, Wirestam L, Dahle C, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, et al. Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus. Journal of Autoimmunity. 102340. PMID 31629628 DOI: 10.1016/J.Jaut.2019.102340 |
0.428 |
|
| 2019 |
Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, et al. Economic evaluation of damage accrual in an international SLE inception cohort using a multi-state model approach. Arthritis Care & Research. PMID 31609532 DOI: 10.1002/Acr.24092 |
0.331 |
|
| 2019 |
Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, et al. Peripheral nervous system disease in Systemic Lupus Erythematosus: Results from an international, inception cohort study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31390162 DOI: 10.1002/Art.41070 |
0.447 |
|
| 2019 |
Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, ... ... Urowitz M, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31385462 DOI: 10.1002/Art.40930 |
0.633 |
|
| 2019 |
Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, ... ... Urowitz M, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Annals of the Rheumatic Diseases. PMID 31383717 DOI: 10.1136/Annrheumdis-2018-214819 |
0.633 |
|
| 2019 |
Webber D, Cao J, Dominguez D, Gladman DD, Levy DM, Ng L, Paterson AD, Touma Z, Urowitz MB, Wither JE, Silverman ED, Hiraki LT. Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE. Rheumatology (Oxford, England). PMID 31236574 DOI: 10.1093/Rheumatology/Kez220 |
0.622 |
|
| 2019 |
Tselios K, Gladman DD, Sheane BJ, Su J, Urowitz M. All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013). Annals of the Rheumatic Diseases. PMID 30992296 DOI: 10.1136/Annrheumdis-2018-214802 |
0.422 |
|
| 2019 |
Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, ... Urowitz MB, et al. Construction of a frailty index as a novel health measure in systemic lupus erythematosus. The Journal of Rheumatology. PMID 30988130 DOI: 10.3899/Jrheum.181338 |
0.456 |
|
| 2019 |
Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, ... Urowitz MB, et al. Evaluating the properties of a frailty index and its association with mortality risk among patients with systemic lupus erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). PMID 30771242 DOI: 10.1002/Art.40859 |
0.457 |
|
| 2019 |
Mendel A, Bernatsky S, Pineau CA, St-Pierre Y, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, et al. Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen. Rheumatology (Oxford, England). PMID 30753683 DOI: 10.1093/Rheumatology/Kez014 |
0.306 |
|
| 2019 |
Urowitz MB, Su J, Gladman DD. Atherosclerotic Vascular Events in Systemic Lupus Erythematosus - an Evolving Story. The Journal of Rheumatology. PMID 30709950 DOI: 10.3899/Jrheum.180986 |
0.421 |
|
| 2019 |
Tedeschi SK, Johnson SR, Boumpas DT, Daikh D, Dörner T, Diamond B, Jacobsen S, Jayne D, Kamen DL, McCune WJ, Mosca M, Ramsey-Goldman R, Ruiz-Irastorza G, Schneider M, Urowitz M, et al. Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus. Annals of the Rheumatic Diseases. PMID 30692164 DOI: 10.1136/Annrheumdis-2018-214685 |
0.339 |
|
| 2019 |
Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, et al. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort. The Journal of Rheumatology. PMID 30647177 DOI: 10.3899/Jrheum.180713 |
0.482 |
|
| 2019 |
Urowitz MB, Ohsfeldt RL, Wielage RC, Kelton KA, Asukai Y, Ramachandran S. Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis. Annals of the Rheumatic Diseases. PMID 30610066 DOI: 10.1136/Annrheumdis-2018-214043 |
0.405 |
|
| 2019 |
Webber D, Cao J, Dominguez D, Gladman DD, Levy D, Ng L, Paterson A, Touma Z, Urowitz MB, Wither J, Silverman ED, Hiraki LT. 60 Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset with SLE Lupus Science & Medicine. 6. DOI: 10.1136/Lupus-2019-Lsm.60 |
0.619 |
|
| 2019 |
Clarke AE, Barber MR, Pierre YS, Urowitz MB, Gladman DD, Bernatsky S, Vinet E, Pineau C, Hanly J, Peschken C, Fortin P, Jung M, Barber C, Elliott S. 56 Self-reported indirect costs are underestimated in a canadian cohort of patients with SLE Lupus Science & Medicine. 6. DOI: 10.1136/Lupus-2019-Lsm.56 |
0.361 |
|
| 2019 |
Sivakumaran J, Harvey P, Omar A, Urowitz MB, Gladman DD, Anderson N, Su J, Touma Z. 291 Assessment of the QRISK2, QRISK3, SLE cardiovascular risk equation, modified framingham and framingham risk calculators as predictors of cardiovascular disease events in systemic lupus erythematosus Lupus Science & Medicine. 6. DOI: 10.1136/Lupus-2019-Lsm.291 |
0.619 |
|
| 2019 |
Touma Z, Gladman DD, Fei K, Gregan YI, Gordon R, Lo KH, Rose S, Urowitz MB. 10 Performance of SLEDAI-2K Responder Index-50 in a Randomized Placebo-Controlled Trial with Ustekinumab (UST) in Systemic Lupus Erythematosus Lupus Science & Medicine. 6. DOI: 10.1136/Lupus-2019-Lsm.10 |
0.655 |
|
| 2019 |
Furie R, Bruce IN, Dörner T, Leon MG, Leszczynski P, Urowitz MB, Haier B, Jimenez T, Barbey C, Liu J, Stach C. Fri0195 Efficacy And Safety Of Dapirolizumab Pegol (Dzp) In Patients With Moderately To Severely Active Systemic Lupus Erythematosus (Sle): A Randomised, Placebo (Pbo)-Controlled Study Annals of the Rheumatic Diseases. 78: 775-776. DOI: 10.1136/Annrheumdis-2019-Eular.5529 |
0.349 |
|
| 2019 |
Touma Z, Gladman DD, Rose S, Fei K, Gregan YI, Gordon R, Lo KH, Urowitz MB. Thu0250 Early Improvement In Sledai-2K Responder Index-50 Predicts Sri-4 Response In A Randomized Placebo-Controlled Trial Of Ustekinumab (Ust) In Systemic Lupus Erythematosus Annals of the Rheumatic Diseases. 78: 402-403. DOI: 10.1136/Annrheumdis-2019-Eular.230 |
0.618 |
|
| 2019 |
Hanly J, Qiuju L, Su L, Urowitz MB, Gordon C, Bae S, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg D, Rahman A, Merrill JT, Fortin P, et al. Op0252 Neuropathies In Systemic Lupus Erythematosus: Results From An International, Inception Cohort Study Annals of the Rheumatic Diseases. 78: 206-207. DOI: 10.1136/Annrheumdis-2019-Eular.1820 |
0.438 |
|
| 2019 |
Sivakumaran J, Harvey P, Su J, Omar A, Anderson N, Gladman DD, Urowitz MB, Touma Z. Thu0688 Assessment Of The Qrisk2, Qrisk3, Sle Cardiovascular Risk Equation, Framingham And Modified Framingham Risk Calculators As Predictors Of Cardiovascular Disease Events In Systemic Lupus Erythematosus Annals of the Rheumatic Diseases. 78: 641-643. DOI: 10.1136/Annrheumdis-2019-Eular.1146 |
0.615 |
|
| 2018 |
Mendel A, Bernatsky SB, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon JP, Isenberg DA, Rahman A, Ginzler EM, Petri M, et al. Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort. Annals of the Rheumatic Diseases. PMID 30573656 DOI: 10.1136/Annrheumdis-2018-214434 |
0.356 |
|
| 2018 |
Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB. Disease course patterns in systemic lupus erythematosus. Lupus. 961203318817132. PMID 30526328 DOI: 10.1177/0961203318817132 |
0.638 |
|
| 2018 |
Tselios K, Yap KS, Pakchotanon R, Polachek A, Su J, Urowitz MB, Gladman DD. Correction to: Psoriasis in systemic lupus erythematosus: a single-center experience. Clinical Rheumatology. PMID 30430267 DOI: 10.1007/S10067-018-4363-0 |
0.311 |
|
| 2018 |
Tselios K, Gladman DD, Urowitz MB. How can we define low disease activity in systemic lupus erythematosus? Seminars in Arthritis and Rheumatism. PMID 30415943 DOI: 10.1016/J.Semarthrit.2018.10.013 |
0.458 |
|
| 2018 |
Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, et al. Psychosis in Systemic Lupus Erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). PMID 30375754 DOI: 10.1002/Art.40764 |
0.439 |
|
| 2018 |
Tselios K, Deeb M, Gladman DD, Harvey P, Akhtari S, Mak S, Butany J, Urowitz MB. Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered? The Journal of Rheumatology. PMID 30323009 DOI: 10.3899/Jrheum.180124 |
0.475 |
|
| 2018 |
Keeling SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, Bergeron L, Bernatsky S, Bourre-Tessier J, Clarke A, Baril-Dionne A, Dutz J, Ensworth S, Fifi-Mah A, Fortin PR, Gladman DD, Haaland D, ... ... Urowitz M, et al. Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 30173152 DOI: 10.3899/Jrheum.171459 |
0.646 |
|
| 2018 |
Tselios K, Gladman DD, Harvey P, Akhtari S, Su J, Urowitz MB. Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials? The Journal of Rheumatology. PMID 30068764 DOI: 10.3899/Jrheum.171436 |
0.432 |
|
| 2018 |
Keeling SO, Bissonauth A, Bernatsky S, Vandermeer B, Fortin PR, Gladman DD, Peschken C, Urowitz MB. Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada. The Journal of Rheumatology. PMID 30068762 DOI: 10.3899/Jrheum.171307 |
0.411 |
|
| 2018 |
Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB. Clinical remission and low disease activity have comparable outcomes over 10 years in systemic lupus erythematosus. Arthritis Care & Research. PMID 30055090 DOI: 10.1002/Acr.23720 |
0.637 |
|
| 2018 |
Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, et al. Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort. Arthritis Care & Research. PMID 30044551 DOI: 10.1002/Acr.23712 |
0.334 |
|
| 2018 |
Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB. Monophasic Disease Course in Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 29858240 DOI: 10.3899/Jrheum.171319 |
0.681 |
|
| 2018 |
Touma Z, Gladman DD, Su J, Anderson N, Urowitz MB. A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid index. Rheumatology (Oxford, England). PMID 29688532 DOI: 10.1093/Rheumatology/Key103 |
0.561 |
|
| 2018 |
Tselios K, Gladman DD, Harvey P, Su J, Urowitz MB. Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors. Lupus. 961203318770526. PMID 29665757 DOI: 10.1177/0961203318770526 |
0.477 |
|
| 2018 |
Tanwani J, Tselios K, Gladman DD, Su J, Urowitz MB. Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies. Lupus. 961203318770018. PMID 29642752 DOI: 10.1177/0961203318770018 |
0.493 |
|
| 2018 |
Little J, Parker B, Lunt M, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, et al. Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort. Rheumatology (Oxford, England). PMID 29361147 DOI: 10.1093/Rheumatology/Kex444 |
0.309 |
|
| 2018 |
Bernatsky S, Ramsey-Goldman R, Petri M, Urowitz MB, Gladman DD, Fortin PR, Yelin EH, Ginzler E, Hanly JG, Peschken C, Gordon C, Nived O, Aranow C, Bae SC, Isenberg D, et al. Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 29335347 DOI: 10.3899/Jrheum.170652 |
0.358 |
|
| 2018 |
Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin P, et al. Cerebrovascular Events in Systemic Lupus Erythematosus. Arthritis Care & Research. PMID 29316357 DOI: 10.1002/Acr.23509 |
0.423 |
|
| 2018 |
Keeling S, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, Bergeron L, Bernatsky S, Bourre-Tessier J, Clarke A, Baril-Dionne A, Dutz J, Ensworth S, Fifi-Mah A, Fortin PR, Gladman D, Haaland D, ... ... Urowitz M, et al. CS-36 Recommendations for the assessment of systemic lupus erythematosus in canada Lupus Science & Medicine. 5. DOI: 10.1136/Lupus-2018-Lsm.71 |
0.63 |
|
| 2018 |
Tselios K, Gladman DD, Harvey P, Akhtari S, Su J, Urowitz MB. CS-14 Prolonged antimalarial treatment is associated with increased risk for elevated myocardial biomarkers in systemic lupus erythematosus Lupus Science & Medicine. 5. DOI: 10.1136/Lupus-2018-Lsm.49 |
0.415 |
|
| 2018 |
Clarke AE, Bruce IN, Urowitz MB, Hanly JG, Romero-Diaz J, Gordon C, Bae S, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley M, et al. CS-07 Economic evaluation of damage accrual in an international SLE inception cohort Lupus Science & Medicine. 5. DOI: 10.1136/Lupus-2018-Lsm.42 |
0.313 |
|
| 2018 |
Eudy A, Petri M, Fischer-Betz R, Mokbel A, Nalli C, Andreoli L, Tincani A, Molad Y, Gladman D, Urowitz M. PS4:80 Hydroxychloroquine in lupus pregnancy: a meta-analysis of individual participant data Lupus Science & Medicine. 5. DOI: 10.1136/Lupus-2018-Abstract.125 |
0.322 |
|
| 2018 |
Touma Z, Gladman D, Su J, Anderson NM, Urowitz MB. FRI0395 Sle disease activity index glucocorticoid index (SLEDAI-2KG) identifies more responders than sledai-2k Annals of the Rheumatic Diseases. 77: 730-731. DOI: 10.1136/Annrheumdis-2018-Eular.5519 |
0.603 |
|
| 2018 |
Aringer M, Costenbader KH, Brinks R, Boumpas D, Daikh D, Jayne D, Kamen D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Diamond B, Jacobsen S, McCune WJ, Ruiz-Irastorza G, ... ... Urowitz MB, et al. OP0020 Validation of new systemic lupus erythematosus classification criteria Annals of the Rheumatic Diseases. 77: 60-60. DOI: 10.1136/Annrheumdis-2018-Eular.3679 |
0.617 |
|
| 2017 |
Ferreira I, Croca S, Raimondo MG, Matharu M, Miller S, Giles I, Isenberg D, Ioannou Y, Hanly JG, Urowitz MB, Anderson N, Aranow C, Askanase A, Bae SC, Bernatsky S, et al. Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study. Arthritis Research & Therapy. 19: 287. PMID 29273092 DOI: 10.1186/S13075-017-1495-6 |
0.429 |
|
| 2017 |
Barber MRW, Hanly JG, Su L, Urowitz MB, Pierre YS, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, et al. Economic evaluation of lupus nephritis in the Systemic Lupus International Collaborating Clinics inception cohort using a multistate model approach. Arthritis Care & Research. PMID 29193883 DOI: 10.1002/Acr.23480 |
0.401 |
|
| 2017 |
Pakchotanon R, Gladman DD, Su J, Urowitz MB. More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 29142038 DOI: 10.3899/Jrheum.170645 |
0.504 |
|
| 2017 |
Tselios K, Gladman DD, Su J, Ace O, Urowitz MB. Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study. The Journal of Rheumatology. PMID 29093154 DOI: 10.3899/Jrheum.161121 |
0.458 |
|
| 2017 |
Kalunian KC, Urowitz MB, Isenberg D, Merrill JT, Petri M, Furie RA, Morgan-Cox MA, Taha R, Watts S, Silk M, Linnik MD. Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index. Rheumatology (Oxford, England). PMID 29045736 DOI: 10.1093/Rheumatology/Kex368 |
0.351 |
|
| 2017 |
Tselios K, Deeb M, Gladman DD, Harvey P, Urowitz MB. Antimalarial-induced cardiomyopathy: a systematic review of the literature. Lupus. 961203317734922. PMID 28992800 DOI: 10.1177/0961203317734922 |
0.346 |
|
| 2017 |
Pakchotanon R, Gladman DD, Su J, Urowitz MB. Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis. Lupus. 961203317726376. PMID 28857717 DOI: 10.1177/0961203317726376 |
0.331 |
|
| 2017 |
Chamberlain C, Colman PJ, Ranger AM, Burkly LC, Johnston GI, Otoul C, Stach C, Zamacona M, Dörner T, Urowitz M, Hiepe F. Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles. Annals of the Rheumatic Diseases. PMID 28780512 DOI: 10.1136/Annrheumdis-2017-211388 |
0.424 |
|
| 2017 |
Deeb M, Tselios K, Gladman DD, Su J, Urowitz MB. Shrinking lung syndrome in systemic lupus erythematosus: a single-centre experience. Lupus. 961203317722411. PMID 28758573 DOI: 10.1177/0961203317722411 |
0.391 |
|
| 2017 |
Tselios K, Urowitz MB. Cardiovascular and Pulmonary Manifestations of Systemic Lupus Erythematosus. Current Rheumatology Reviews. 13: 206-218. PMID 28675998 DOI: 10.2174/1573397113666170704102444 |
0.429 |
|
| 2017 |
Gu K, Gladman DD, Su J, Urowitz MB. Hospitalizations in Patients with Systemic Lupus Erythematosus in an Academic Health Science Center. The Journal of Rheumatology. PMID 28620060 DOI: 10.3899/Jrheum.170072 |
0.434 |
|
| 2017 |
Aljohani R, Gladman DD, Su J, Urowitz MB. Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics. Clinical Rheumatology. PMID 28589322 DOI: 10.1007/S10067-017-3713-7 |
0.486 |
|
| 2017 |
Gladman DD, Dhillon N, Su J, Urowitz MB. Osteonecrosis in SLE: prevalence, patterns, outcomes and predictors. Lupus. 961203317711012. PMID 28530464 DOI: 10.1177/0961203317711012 |
0.492 |
|
| 2017 |
Aljohani R, Gladman DD, Su J, Urowitz MB. Disease evolution in late-onset and early-onset systemic lupus erythematosus. Lupus. 961203317696593. PMID 28420066 DOI: 10.1177/0961203317696593 |
0.476 |
|
| 2017 |
Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, et al. The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients. Lupus. 961203317692437. PMID 28420054 DOI: 10.1177/0961203317692437 |
0.392 |
|
| 2017 |
Isenberg D, Sturgess J, Allen E, Aranow C, Askanase A, Sang-Cheol B, Bernatsky S, Bruce I, Buyon J, Cervera R, Clarke A, Dooley MA, Fortin P, Ginzler E, Gladman D, ... ... Urowitz M, et al. A study of flare assessment in systemic lupus erythematosus (SLE) based on paper patients. Arthritis Care & Research. PMID 28388813 DOI: 10.1002/Acr.23252 |
0.485 |
|
| 2017 |
Al Rayes H, Harvey PJ, Gladman DD, Su J, Sabapathy A, Urowitz MB, Touma Z. Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease. Arthritis Research & Therapy. 19: 31. PMID 28183339 DOI: 10.1186/S13075-017-1240-1 |
0.667 |
|
| 2017 |
Tselios K, Yap KS, Pakchotanon R, Polachek A, Su J, Urowitz MB, Gladman DD. Psoriasis in systemic lupus erythematosus: a single-center experience. Clinical Rheumatology. PMID 28168661 DOI: 10.1007/S10067-017-3566-0 |
0.48 |
|
| 2017 |
Tselios K, Gladman DD, Urowitz MB. Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies. Open Access Rheumatology : Research and Reviews. 9: 1-9. PMID 28053559 DOI: 10.2147/Oarrr.S123549 |
0.331 |
|
| 2017 |
Chamberlain C, Colman P, Ranger A, Johnson G, Otoul C, Stach C, Dörner T, Urowitz M, Hiepe F. 90 Safety, efficacy and transcriptional changes following repeated administration of dapirolizumab pegol in patients with systemic lupus erythematosus: results from a phase i study Lupus Science & Medicine. 4. DOI: 10.1136/Lupus-2017-000215.90 |
0.419 |
|
| 2017 |
Choi M, Clarke A, Pierre YS, Hanly J, Urowitz M, Gladman D, Pike S, Fritzler M. 400 Ana-negative sle: re-evaluation in an international inception cohort Lupus Science & Medicine. 4. DOI: 10.1136/Lupus-2017-000215.400 |
0.339 |
|
| 2017 |
Kalunian K, Urowitz M, Isenberg D, Merrill J, Petri M, Furie R, Morgan-Cox M, Taha R, Silk M, Linnik M. 28 Drivers of the sle responder index (sri-5) endpoint in clinical trials of sle Lupus Science & Medicine. 4. DOI: 10.1136/Lupus-2017-000215.28 |
0.397 |
|
| 2017 |
Petri M, Kalunian K, Urowitz M, Furie R, Morgan-Cox M, Silk M, Dow E, Higgs R, Watts S, Isenberg D, Linnik M. 24 A molecular signature based on ifn gene signature and serology defines two populations of patients with different baseline disease activity Lupus Science & Medicine. 4. DOI: 10.1136/Lupus-2017-000215.24 |
0.439 |
|
| 2017 |
Medina-Rosas J, Gladman D, Su J, Urowitz M, Touma Z. 219 Effect of complete or partial proteinuria recovery compared to no recovery at 2 years after the diagnosis of lupus nephritis on long term outcomes Lupus Science & Medicine. 4. DOI: 10.1136/Lupus-2017-000215.219 |
0.543 |
|
| 2017 |
Urowitz M, Gladman D, Su J, Anderson N. 176 Accrual of disease comorbidities over 8 years in a multicentre inception sle cohort Lupus Science & Medicine. 4. DOI: 10.1136/Lupus-2017-000215.176 |
0.388 |
|
| 2017 |
Urowitz M, Wielage R, Kelton K, Ohsfeldt R, Asukai Y, Ramachandran S. FRI0298 Application of propensity score-matching methods to compare data from long-term extension trials with data from an existing lupus registry Annals of the Rheumatic Diseases. 76: 599-599. DOI: 10.1136/Annrheumdis-2017-Eular.5071 |
0.437 |
|
| 2016 |
van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L, Askanase A, Balážová P, Bonfa E, Bootsma H, Boumpas D, Bruce I, Cervera R, Clarke A, Coney C, ... ... Urowitz M, et al. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS). Annals of the Rheumatic Diseases. PMID 27884822 DOI: 10.1136/Annrheumdis-2016-209519 |
0.381 |
|
| 2016 |
Yap KS, Urowitz MB, Mahood Q, Medina-Rosas J, Sabapathy A, Lawson D, Su J, Gladman DD, Touma Z. The utility of lupus serology in predicting outcomes of renal transplantation in lupus patients: Systematic literature review and analysis of the Toronto lupus cohort. Seminars in Arthritis and Rheumatism. PMID 27769590 DOI: 10.1016/J.Semarthrit.2016.09.008 |
0.575 |
|
| 2016 |
Polachek A, Gladman DD, Su J, Urowitz MB. Defining low disease activity in systemic lupus erythematosus. Arthritis Care & Research. PMID 27696791 DOI: 10.1002/Acr.23109 |
0.448 |
|
| 2016 |
Bernatsky S, Ramsey-Goldman R, Petri M, Urowitz MB, Gladman DD, Fortin PF, Ginzler E, Romero-Diaz J, Peschken C, Jacobsen S, Hanly JG, Gordon C, Nived O, Yelin EH, Isenberg D, et al. Breast cancer in systemic lupus. Lupus. PMID 27687028 DOI: 10.1177/0961203316664595 |
0.352 |
|
| 2016 |
Tselios K, Gladman DD, Su J, Urowitz MB. Dr. Tselios, et al reply. The Journal of Rheumatology. 43: 1767. PMID 27587017 DOI: 10.3899/Jrheum.160749 |
0.408 |
|
| 2016 |
Cramarossa G, Urowitz MB, Su J, Gladman D, Touma Z. Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus. Lupus. PMID 27522094 DOI: 10.1177/0961203316664597 |
0.613 |
|
| 2016 |
Tselios K, Gladman DD, Harvey P, Mak S, Chantal M, Butany J, Urowitz MB. Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. 22: 287-8. PMID 27464781 DOI: 10.1097/Rhu.0000000000000400 |
0.423 |
|
| 2016 |
Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, Ruiz-Irastorza G, Hughes G. Systemic lupus erythematosus. Nature Reviews. Disease Primers. 2: 16039. PMID 27306639 DOI: 10.1097/00005792-199303000-00005 |
0.643 |
|
| 2016 |
Sheane BJ, Gladman DD, Su J, Urowitz MB. Disease outcomes in corticosteroid-naïve patients with systemic lupus erythematosus. Arthritis Care & Research. PMID 27214378 DOI: 10.1002/Acr.22938 |
0.437 |
|
| 2016 |
Urowitz MB, Gladman DD, Anderson NM, Su J, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke A, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg D, Rahman A, et al. Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort. Lupus Science & Medicine. 3: e000143. PMID 27099765 DOI: 10.1136/Lupus-2015-000143 |
0.449 |
|
| 2016 |
Bruce IN, Urowitz M, van Vollenhoven R, Aranow C, Fettiplace J, Oldham M, Wilson B, Molta C, Roth D, Gordon D. Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care. Lupus. PMID 26936891 DOI: 10.1177/0961203315625119 |
0.345 |
|
| 2016 |
Urowitz MB, Ibañez D, Su J, Gladman DD. Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 26879352 DOI: 10.3899/Jrheum.150983 |
0.466 |
|
| 2016 |
Tselios K, Gladman DD, Su J, Urowitz MB. Does renin-angiotensin system blockade protect lupus nephritis patients from atherosclerotic cardiovascular events? A case-control study. Arthritis Care & Research. PMID 26866934 DOI: 10.1002/Acr.22857 |
0.349 |
|
| 2016 |
Tselios K, Gladman DD, Su J, Urowitz MB. Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study. The Journal of Rheumatology. PMID 26773121 DOI: 10.3899/Jrheum.150779 |
0.455 |
|
| 2016 |
Tselios K, Sheane BJ, Gladman DD, Urowitz MB. Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review. The Journal of Rheumatology. 43: 54-65. PMID 26568591 DOI: 10.3899/Jrheum.150460 |
0.421 |
|
| 2016 |
Touma Z, Gladman DD, Su J, Urowitz MB. CE-18 Time to recovery of individual lupus manifestations on standard of care treatment Lupus Science & Medicine. 3. DOI: 10.1136/Lupus-2016-000179.97 |
0.646 |
|
| 2016 |
Choi M, Clarke A, Hanly JG, Urowitz M, Romero-Diaz J, Gordon C, Bae S, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin PR, Gladman D, et al. CE-21 The prevalence and determinants of ANTI-DFS70 antibodies in an international inception cohort of systemic lupus erythematosus (SLE) patients Lupus Science & Medicine. 3. DOI: 10.1136/Lupus-2016-000179.100 |
0.362 |
|
| 2016 |
Touma Z, Urowitz MB. Systemic Glucocorticoids Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects. 521-531. DOI: 10.1016/B978-0-12-801917-7.00061-9 |
0.581 |
|
| 2015 |
Tselios K, Koumaras C, Gladman DD, Urowitz MB. Dyslipidemia in systemic lupus erythematosus: just another comorbidity? Seminars in Arthritis and Rheumatism. PMID 26711309 DOI: 10.1016/J.Semarthrit.2015.10.010 |
0.451 |
|
| 2015 |
Tselios K, Gladman DD, Su J, Urowitz MB. Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus. Lupus. PMID 26585070 DOI: 10.1177/0961203315617845 |
0.364 |
|
| 2015 |
Steiman AJ, Gladman DD, Ibañez D, Noamani B, Landolt-Marticorena C, Urowitz MB, Wither JE. Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus. The Journal of Rheumatology. 42: 2318-26. PMID 26568589 DOI: 10.3899/Jrheum.150040 |
0.392 |
|
| 2015 |
Medina-Rosas J, Gladman DD, Su J, Sabapathy A, Urowitz MB, Touma Z. Utility of untimed single urine protein/creatinine ratio as a substitute for 24-h proteinuria for assessment of proteinuria in systemic lupus erythematosus. Arthritis Research & Therapy. 17: 296. PMID 26497948 DOI: 10.1186/S13075-015-0808-X |
0.519 |
|
| 2015 |
Drucker AM, Su J, Mussani F, Siddha SK, Gladman DD, Urowitz MB. Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study. Lupus. PMID 26453664 DOI: 10.1177/0961203315610645 |
0.496 |
|
| 2015 |
Hanly JG, O'Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin P, et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford, England). PMID 26342222 DOI: 10.1093/Rheumatology/Kev311 |
0.313 |
|
| 2015 |
Isenberg DA, Petri M, Kalunian K, Tanaka Y, Urowitz MB, Hoffman RW, Morgan-Cox M, Iikuni N, Silk M, Wallace DJ. Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study. Annals of the Rheumatic Diseases. PMID 26338095 DOI: 10.1136/Annrheumdis-2015-207653 |
0.387 |
|
| 2015 |
Urowitz MB, Isenberg DA, Wallace DJ. Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study. Lupus Science & Medicine. 2: e000104. PMID 26301100 DOI: 10.1136/Lupus-2015-000104 |
0.402 |
|
| 2015 |
Touma Z, Gladman DD, Su J, Ibañez D, Urowitz MB. SLEDAI-2K Does Not Conceal Worsening in a Particular System When There Is Overall Improvement. The Journal of Rheumatology. 42: 1401-5. PMID 26077403 DOI: 10.3899/Jrheum.141088 |
0.657 |
|
| 2015 |
Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, et al. Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis & Rheumatology (Hoboken, N.J.). 67: 1837-47. PMID 25778456 DOI: 10.1002/Art.39111 |
0.431 |
|
| 2015 |
Steiman AJ, Urowitz MB, Ibañez D, Li TT, Gladman DD, Wither J. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus. The Journal of Rheumatology. 42: 810-6. PMID 25729033 DOI: 10.3899/Jrheum.140796 |
0.417 |
|
| 2015 |
Chang NH, Li TT, Kim JJ, Landolt-Marticorena C, Fortin PR, Gladman DD, Urowitz MB, Wither JE. Interferon-α induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus. Journal of Autoimmunity. 58: 100-10. PMID 25678471 DOI: 10.1016/J.Jaut.2015.01.009 |
0.323 |
|
| 2015 |
Ding JY, Ibañez D, Gladman DD, Urowitz MB. Isolated hematuria and sterile pyuria may indicate systemic lupus erythematosus activity. The Journal of Rheumatology. 42: 437-40. PMID 25593226 DOI: 10.3899/Jrheum.140415 |
0.483 |
|
| 2015 |
Li T, Prokopec SD, Morrison S, Lou W, Reich H, Gladman D, Urowitz M, Scholey J, Fortin PR, Boutros PC, Wither J, Landolt-Marticorena C. Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus. Rheumatology (Oxford, England). 54: 449-57. PMID 25193804 DOI: 10.1093/Rheumatology/Keu326 |
0.368 |
|
| 2015 |
Clarke AE, Urowitz MB, Monga N, Hanly JG. Costs associated with severe and nonsevere systemic lupus erythematosus in Canada. Arthritis Care & Research. 67: 431-6. PMID 25185936 DOI: 10.1002/Acr.22452 |
0.389 |
|
| 2015 |
Orbai AM, Truedsson L, Sturfelt G, Nived O, Fang H, Alarcón GS, Gordon C, Merrill J, Fortin PR, Bruce IN, Isenberg DA, Wallace DJ, Ramsey-Goldman R, Bae SC, Hanly JG, ... ... Urowitz MB, et al. Anti-C1q antibodies in systemic lupus erythematosus. Lupus. 24: 42-9. PMID 25124676 DOI: 10.1177/0961203314547791 |
0.446 |
|
| 2015 |
Bourré-Tessier J, Urowitz MB, Clarke AE, Bernatsky S, Krantz MJ, Huynh T, Joseph L, Belisle P, Bae SC, Hanly JG, Wallace DJ, Gordon C, Isenberg D, Rahman A, Gladman DD, et al. Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort. Arthritis Care & Research. 67: 128-35. PMID 24838943 DOI: 10.1002/Acr.22370 |
0.475 |
|
| 2015 |
Parker B, Urowitz MB, Gladman DD, Lunt M, Donn R, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, et al. Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Annals of the Rheumatic Diseases. 74: 1530-6. PMID 24692585 DOI: 10.1136/Annrheumdis-2013-203933 |
0.455 |
|
| 2015 |
Haddad A, Gladman DD, Ibañez D, Urowitz MB. Vascular- and pregnancy-related outcomes in patients with systemic lupus erythematosus with positive antiphospholipid profile and thrombocytopenia Lupus. 24: 822-826. DOI: 10.1177/0961203314565689 |
0.455 |
|
| 2015 |
Medina J, Gladman D, Urowitz M, Su J, Sabapaty A, Touma Z. SAT0404 Spot Urine Protein/Creatinine Ratio is Useful in Screening for Proteinuria but Should Not Substitute 24 hours Urine Collection Sample to Quantify Proteinuria in Lupus Annals of the Rheumatic Diseases. 74: 805.2-806. DOI: 10.1136/Annrheumdis-2015-Eular.4852 |
0.534 |
|
| 2015 |
Vollenhoven RFv, Aranow C, Bertsias G, Bonfá E, Cervera R, Costedoat-Chalumeau N, Dörner T, Houssiau F, Lerstrom K, Morand E, Mosca M, Navarra S, Petri M, Urowitz M, Voskuijl A, et al. OP0092 Remission in Sle: Consensus Findings from a Large International Panel on Definitions of Remission in SLE (DORIS) Annals of the Rheumatic Diseases. 74: 103-103. DOI: 10.1136/Annrheumdis-2015-Eular.4666 |
0.364 |
|
| 2014 |
Steiman AJ, Urowitz MB, Ibañez D, Papneja A, Gladman DD. Prolonged clinical remission in patients with systemic lupus erythematosus. The Journal of Rheumatology. 41: 1808-16. PMID 25086082 DOI: 10.3899/Jrheum.131137 |
0.509 |
|
| 2014 |
Eder L, Gladman DD, Ibañez D, Urowitz MB. The correlation between carotid artery atherosclerosis and clinical ischemic heart disease in lupus patients. Lupus. 23: 1142-8. PMID 24876099 DOI: 10.1177/0961203314537696 |
0.385 |
|
| 2014 |
Bruce IN, O'Keeffe AG, Farewell V, Hanly JG, Manzi S, Su L, Gladman DD, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, ... ... Urowitz MB, et al. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Annals of the Rheumatic Diseases. PMID 24834926 DOI: 10.1136/Annrheumdis-2013-205171 |
0.485 |
|
| 2014 |
Al Maimouni H, Gladman DD, Ibañez D, Urowitz MB. Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes. Arthritis Care & Research. 66: 1905-9. PMID 24821661 DOI: 10.1002/Acr.22364 |
0.338 |
|
| 2014 |
Urowitz M, Gladman DD, Ibañez D, Sanchez-Guerrero J, Bae SC, Gordon C, Fortin PR, Clarke A, Bernatsky S, Hanly JG, Wallace DJ, Isenberg D, Rahman A, Merrill J, Ginzler E, et al. Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus. Arthritis Care & Research. 66: 1374-9. PMID 24497416 DOI: 10.1002/acr.22299 |
0.307 |
|
| 2014 |
Lertratanakul A, Wu P, Dyer A, Urowitz M, Gladman D, Fortin P, Bae SC, Gordon C, Clarke A, Bernatsky S, Hanly JG, Isenberg D, Rahman A, Merrill J, Wallace DJ, et al. 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. Arthritis Care & Research. 66: 1167-76. PMID 24470118 DOI: 10.1002/Acr.22291 |
0.372 |
|
| 2014 |
Touma Z, Urowitz MB, Ibañez D, Gladman DD. Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment. The Journal of Rheumatology. 41: 688-97. PMID 24429170 DOI: 10.3899/Jrheum.130005 |
0.607 |
|
| 2014 |
Tselios K, Koumaras C, Urowitz MB, Gladman DD. Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisal. Seminars in Arthritis and Rheumatism. 43: 521-5. PMID 23953498 DOI: 10.1016/J.Semarthrit.2013.07.007 |
0.439 |
|
| 2014 |
Bernatsky S, Ramsey-Goldman R, Joseph L, Boivin JF, Costenbader KH, Urowitz MB, Gladman DD, Fortin PR, Nived O, Petri MA, Jacobsen S, Manzi S, Ginzler EM, Isenberg D, Rahman A, et al. Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Annals of the Rheumatic Diseases. 73: 138-42. PMID 23303389 DOI: 10.1136/Annrheumdis-2012-202099 |
0.456 |
|
| 2014 |
Bernatsky S, Ramsey-Goldman R, Boivin J, Joseph L, Petri MA, Zoma A, Manzi S, Urowitz MB, Gladman DD, Fortin PR, Ginzler EM, Yelin E, Bae S, Wallace DJ, Edworthy SM, et al. Cancer risk factors in systemic lupus erythematosus: multivariate regression analysis in 16,409 patients Arthritis Research & Therapy. 16: A35. DOI: 10.1186/Ar4651 |
0.423 |
|
| 2014 |
Touma Z, Gladman D, Ibanez D, Urowitz M. OP0042 Do We Know How and When to Stop Immunosuppressants in Lupus Patients? Annals of the Rheumatic Diseases. 73: 76-76. DOI: 10.1136/Annrheumdis-2014-Eular.5739 |
0.61 |
|
| 2014 |
Zen M, Parker B, Urowitz M, Bruce I. FRI0426 High Prevalence of Overweight and Obesity in Recently Diagnosed Systemic Lupus Erythematosus Patients in an International Registry: Table 1. Annals of the Rheumatic Diseases. 73: 541.1-541. DOI: 10.1136/Annrheumdis-2014-Eular.3158 |
0.392 |
|
| 2014 |
Hanly J, O'Keeffe A, Urowitz M. FRI0407 The Impact of Lupus Nephritis at Inception on Health Related Quality of Life: Results from an International Cohort Study: Table Annals of the Rheumatic Diseases. 73: 534.2-534. DOI: 10.1136/Annrheumdis-2014-Eular.1114 |
0.419 |
|
| 2014 |
Hanly J, O'Keeffe A, Urowitz M. OP0201 Outcome of Lupus Nephritis: Results from an International, Prospective, Inception Cohort Study Annals of the Rheumatic Diseases. 73: 138.3-139. DOI: 10.1136/Annrheumdis-2014-Eular.1113 |
0.469 |
|
| 2013 |
Hanly JG, Urowitz MB, O'Keeffe AG, Gordon C, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Clarke AE, Bernatsky S, Wallace DJ, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Petri M, et al. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. Arthritis and Rheumatism. 65: 2887-97. PMID 24166793 DOI: 10.1002/Art.38106 |
0.461 |
|
| 2013 |
Nikpour M, Gladman DD, Ibanez D, Harvey PJ, Urowitz MB. Assessment of coronary risk based on cumulative exposure to lipids in systemic lupus erythematosus. The Journal of Rheumatology. 40: 2006-14. PMID 24128779 DOI: 10.3899/Jrheum.121273 |
0.538 |
|
| 2013 |
Lu M, Bernatsky S, Ramsey-Goldman R, Petri M, Manzi S, Urowitz MB, Gladman D, Fortin PR, Ginzler EM, Yelin E, Bae SC, Wallace DJ, Jacobsen S, Dooley MA, Peschken CA, et al. Non-lymphoma hematological malignancies in systemic lupus erythematosus. Oncology. 85: 235-40. PMID 24107608 DOI: 10.1186/Ar3998 |
0.41 |
|
| 2013 |
Nikpour M, Gladman DD, Urowitz MB. Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand? Lupus. 22: 1243-50. PMID 24097996 DOI: 10.1177/0961203313493031 |
0.576 |
|
| 2013 |
Eder L, Urowitz MB, Gladman DD. Damage in lupus patients--what have we learned so far? Lupus. 22: 1225-31. PMID 24097994 DOI: 10.1177/0961203313492872 |
0.43 |
|
| 2013 |
Tessier Cloutier B, Clarke AE, Ramsey-Goldman R, Wang Y, Foulkes W, Gordon C, Hansen JE, Yelin E, Urowitz MB, Gladman D, Fortin PR, Wallace DJ, Petri M, Manzi S, Ginzler EM, et al. Breast cancer in systemic lupus erythematosus. Oncology. 85: 117-21. PMID 23887245 DOI: 10.1159/000353138 |
0.347 |
|
| 2013 |
Touma Z, Urowitz MB, Gladman DD. Systemic lupus erythematosus disease activity index 2000 responder index-50 website. The Journal of Rheumatology. 40: 733. PMID 23637378 DOI: 10.3899/Jrheum.130030 |
0.618 |
|
| 2013 |
Akhavan PS, Su J, Lou W, Gladman DD, Urowitz MB, Fortin PR. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus. The Journal of Rheumatology. 40: 831-41. PMID 23588942 DOI: 10.3899/jrheum.120572 |
0.366 |
|
| 2013 |
Urowitz MB, Gordon D, Goldsmith CH, Wolfe F. In memoriam - Hugh A. Smythe, 1927-2012. The Journal of Rheumatology. 40: 343-7. PMID 23547251 DOI: 10.3899/Jrheum.121357 |
0.349 |
|
| 2013 |
Gladman DD, Ibañez D, Ruiz I, Urowitz MB. Recommendations for frequency of visits to monitor systemic lupus erythematosus in asymptomatic patients: data from an observational cohort study. The Journal of Rheumatology. 40: 630-3. PMID 23457385 DOI: 10.3899/Jrheum.121094 |
0.447 |
|
| 2013 |
Touma Z, Gladman DD, Urowitz MB. Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign. Current Opinion in Rheumatology. 25: 164-70. PMID 23370371 DOI: 10.1097/Bor.0B013E32835D2B7B |
0.523 |
|
| 2013 |
Touma Z, Urowitz MB, Gladman DD. Systemic lupus erythematosus: an update on current pharmacotherapy and future directions. Expert Opinion On Biological Therapy. 13: 723-37. PMID 23339281 DOI: 10.1517/14712598.2013.764411 |
0.593 |
|
| 2013 |
Touma Z, Haddad A, Gladman DD, Uleryk EM, Urowitz MB. Skin nontuberculous mycobacterial infection in systemic lupus erythematosus: an unusual skin infection mimicking lupus vasculitis. Seminars in Arthritis and Rheumatism. 42: 498-506. PMID 23332736 DOI: 10.1016/J.Semarthrit.2012.08.002 |
0.568 |
|
| 2013 |
Venner AA, Ibañez D, Gladman DD, Urowitz MB, MacKinnon A, Blasutig IM, Yip PM. Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity. Clinical Biochemistry. 46: 317-20. PMID 23246539 DOI: 10.1016/J.Clinbiochem.2012.12.004 |
0.443 |
|
| 2013 |
Touma Z, Gladman DD, MacKinnon A, Carette S, Abu-Shakra M, Askanase A, Nived O, Hanly JG, Landolt-Marticorena C, Tam LS, Toloza S, Nikpour M, Riddell C, Steiman A, Eder L, ... ... Urowitz MB, et al. Development and assessment of users' satisfaction with the systemic lupus erythematosus disease activity index 2000 responder index-50 website. The Journal of Rheumatology. 40: 34-9. PMID 23118108 DOI: 10.3899/Jrheum.120754 |
0.662 |
|
| 2013 |
Parker B, Urowitz MB, Gladman DD, Lunt M, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, et al. Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Annals of the Rheumatic Diseases. 72: 1308-14. PMID 22945501 DOI: 10.1136/Annrheumdis-2012-202106 |
0.404 |
|
| 2013 |
Touma Z, Urowitz MB, Ibanez D, Taghavi-Zadeh S, Gladman DD. AB0383 Measuring partial and complete recovery in active organ systems of lupus patients on standard of care treatment Annals of the Rheumatic Diseases. 72: A904.2-A904. DOI: 10.1136/Annrheumdis-2013-Eular.2705 |
0.62 |
|
| 2013 |
Touma Z, Urowitz M, Ibañez D, Gladman D. THU0197 Time to recovery from proteinuria in lupus nephritis patients receiving standard of care treatment Annals of the Rheumatic Diseases. 71: 222.1-222. DOI: 10.1136/Annrheumdis-2012-Eular.2162 |
0.584 |
|
| 2013 |
Parker B, Urowitz M, Lunt M, Bruce I. THU0163 Predictors of metabolic syndrome at enrolment into a multicentre international inception cohort of patients with SLE: Annals of the Rheumatic Diseases. 71: 210.3-211. DOI: 10.1136/Annrheumdis-2012-Eular.2128 |
0.433 |
|
| 2013 |
Clarke A, Urowitz M, Monga N, Topors N, Hanly J. AB1311 Healthcare costs of systemic lupus erythematosus (SLE) patients in canada: The impact of disease severity and flares Annals of the Rheumatic Diseases. 71: 712.14-712. DOI: 10.1136/Annrheumdis-2012-Eular.1307 |
0.416 |
|
| 2013 |
Touma Z, Urowitz MB, Gladman DD. Outcome measures in systemic lupus erythematosus Indian Journal of Rheumatology. 8. DOI: 10.1016/J.Injr.2013.11.015 |
0.637 |
|
| 2012 |
Touma Z, Gladman DD, Ibañez D, Urowitz MB. SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 years. Lupus. 21: 1305-11. PMID 22800940 DOI: 10.1177/0961203312454344 |
0.611 |
|
| 2012 |
Touma Z, Urowitz MB, Taghavi-Zadeh S, Ibañez D, Gladman DD. Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months. Rheumatology (Oxford, England). 51: 1814-9. PMID 22718868 DOI: 10.1093/Rheumatology/Kes146 |
0.624 |
|
| 2012 |
Nikpour M, Harvey PJ, Ibanez D, Gladman DD, Urowitz MB. High-sensitivity C-reactive protein as a marker of cardiovascular risk in systemic lupus erythematosus. Arthritis and Rheumatism. 64: 3052-3. PMID 22614710 DOI: 10.1002/Art.34541 |
0.574 |
|
| 2012 |
Borowoy AM, Pope JE, Silverman E, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman D, Urowitz M, Zummer M, Hudson M, Tucker L, Peschken C. Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Seminars in Arthritis and Rheumatism. 42: 179-85. PMID 22595642 DOI: 10.1016/J.Semarthrit.2012.03.011 |
0.396 |
|
| 2012 |
Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, ... ... Urowitz M, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis and Rheumatism. 64: 2677-86. PMID 22553077 DOI: 10.1002/Art.34473 |
0.456 |
|
| 2012 |
Gladman DD, Urowitz MB. University of Toronto Lupus Clinic turns 40. The Journal of Rheumatology. 39: 1074-7. PMID 22550007 DOI: 10.3899/Jrheum.111581 |
0.451 |
|
| 2012 |
Hanly JG, Urowitz MB, Su L, Gordon C, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Wallace DJ, Clarke AE, Ginzler E, Merrill JT, Isenberg DA, Rahman A, Petri M, Fortin PR, et al. Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study. Annals of the Rheumatic Diseases. 71: 1502-9. PMID 22492779 DOI: 10.1136/Annrheumdis-2011-201089 |
0.377 |
|
| 2012 |
Barber C, Herzenberg A, Aghdassi E, Su J, Lou W, Qian G, Yip J, Nasr SH, Thomas D, Scholey JW, Wither J, Urowitz M, Gladman D, Reich H, Fortin PR. Evaluation of clinical outcomes and renal vascular pathology among patients with lupus. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 757-64. PMID 22442181 DOI: 10.2215/Cjn.02870311 |
0.325 |
|
| 2012 |
Wang M, Gladman DD, Ibañez D, Urowitz MB. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus. Arthritis Care & Research. 64: 833-7. PMID 22290935 DOI: 10.1002/Acr.21624 |
0.368 |
|
| 2012 |
Huang D, Aghdassi E, Su J, Mosko J, Hirschfield GM, Gladman DD, Urowitz MB, Fortin PR. Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus. The Journal of Rheumatology. 39: 254-61. PMID 22174205 DOI: 10.3899/Jrheum.110310 |
0.413 |
|
| 2012 |
Steiman AJ, Gladman DD, Ibañez D, Urowitz MB. Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period. Arthritis Care & Research. 64: 511-8. PMID 22162433 DOI: 10.1002/Acr.21568 |
0.484 |
|
| 2012 |
Touma Z, Gladman DD, Ibañez D, Urowitz MB. Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients. Rheumatology (Oxford, England). 51: 528-34. PMID 22120460 DOI: 10.1093/Rheumatology/Ker339 |
0.592 |
|
| 2012 |
Urowitz MB, Gladman DD, Ibañez D, Fortin PR, Bae SC, Gordon C, Clarke A, Bernatsky S, Hanly JG, Isenberg D, Rahman A, Sanchez-Guerrero J, Wallace DJ, Ginzler E, Alarcón GS, et al. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort. Arthritis Care & Research. 64: 132-7. PMID 21954226 DOI: 10.1002/Acr.20648 |
0.497 |
|
| 2012 |
Touma Z, Gladman D, Urowitz M. Development validation and reliability of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 Arthritis Research & Therapy. 14. DOI: 10.1186/Ar3989 |
0.65 |
|
| 2012 |
Clarke A, Bernatsky S, Costenbader K, Urowitz M, Gladman D, Fortin P, Petri M, Manzi S, Isenberg D, Rahman A, Wallace D, Gordon C, Peschken C, Dooley M, Ginzler E, et al. Lymphoma risk in systemic lupus: effects of treatment versus disease activity Arthritis Research & Therapy. 14: 1-28. DOI: 10.1186/Ar3950 |
0.435 |
|
| 2012 |
Touma Z, Gladman DD, Urowitz MB. Clinical Measures, Metrics, and Indices Dubois' Lupus Erythematosus and Related Syndromes: Eighth Edition. 563-581. DOI: 10.1016/B978-1-4377-1893-5.00046-7 |
0.469 |
|
| 2011 |
Urowitz MB, Anton A, Ibanez D, Gladman DD. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus. Arthritis Care & Research. 63: 1517-20. PMID 22034113 DOI: 10.1002/Acr.20599 |
0.34 |
|
| 2011 |
Nikpour M, Urowitz MB, Ibanez D, Harvey PJ, Gladman DD. Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study. Arthritis Research & Therapy. 13: R156. PMID 21955652 DOI: 10.1186/Ar3473 |
0.617 |
|
| 2011 |
Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Clarke A, Bernatsky S, Vasudevan A, Isenberg D, Rahman A, Wallace DJ, Fortin PR, Gladman D, Romero-Diaz J, Romero-Dirz J, et al. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 70: 1726-32. PMID 21893582 DOI: 10.1136/Ard.2010.148502 |
0.468 |
|
| 2011 |
Touma Z, Gladman DD, Ibañez D, Taghavi-Zadeh S, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials. The Journal of Rheumatology. 38: 2395-9. PMID 21885488 DOI: 10.3899/Jrheum.110550 |
0.639 |
|
| 2011 |
Barber CE, Leclerc R, Gladman DD, Urowitz MB, Fortin PR. Posterior reversible encephalopathy syndrome: an emerging disease manifestation in systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 41: 353-63. PMID 21868061 DOI: 10.1016/J.Semarthrit.2011.07.001 |
0.421 |
|
| 2011 |
Touma Z, Gladman DD, Ibañez D, Urowitz MB. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus? The Journal of Rheumatology. 38: 1898-905. PMID 21724700 DOI: 10.3899/Jrheum.110007 |
0.624 |
|
| 2011 |
Florica B, Aghdassi E, Su J, Gladman DD, Urowitz MB, Fortin PR. Peripheral neuropathy in patients with systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 41: 203-11. PMID 21641018 DOI: 10.1016/J.Semarthrit.2011.04.001 |
0.476 |
|
| 2011 |
Vinet E, Clarke AE, Gordon C, Urowitz MB, Hanly JG, Pineau CA, Isenberg D, Rahman A, Wallace D, Alarcón GS, Bruce I, Petri M, Dooley MA, Kalunian K, Maddison P, et al. Decreased live births in women with systemic lupus erythematosus. Arthritis Care & Research. 63: 1068-72. PMID 21425248 DOI: 10.1002/Acr.20466 |
0.369 |
|
| 2011 |
Aghdassi E, Ma DW, Morrison S, Hillyer LM, Clarke S, Gladman DD, Urowitz MB, Fortin PR. Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study. Jpen. Journal of Parenteral and Enteral Nutrition. 35: 198-208. PMID 21378249 DOI: 10.1177/0148607110386378 |
0.425 |
|
| 2011 |
Balitsky AK, Peeva V, Su J, Aghdassi E, Yeo E, Gladman DD, Urowitz MB, Fortin PR. Thrombovascular events affect quality of life in patients with systemic lupus erythematosus. The Journal of Rheumatology. 38: 1017-9. PMID 21362766 DOI: 10.3899/Jrheum.101054 |
0.382 |
|
| 2011 |
Ippolito A, Wallace DJ, Gladman D, Fortin PR, Urowitz M, Werth V, Costner M, Gordon C, Alarcón GS, Ramsey-Goldman R, Maddison P, Clarke A, Bernatsky S, Manzi S, Bae SC, et al. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus. 20: 250-5. PMID 21362750 DOI: 10.1177/0961203310385738 |
0.351 |
|
| 2011 |
Hanly JG, Urowitz MB, Jackson D, Bae SC, Gordon C, Wallace DJ, Clarke A, Bernatsky S, Vasudevan A, Isenberg D, Rahman A, Sanchez-Guerrero J, Romero-Diaz J, Merrill JT, Fortin PR, et al. SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 70: 961-7. PMID 21342917 DOI: 10.1136/Ard.2010.138792 |
0.407 |
|
| 2011 |
Touma Z, Urowitz MB, Fortin PR, Landolt C, Toloza SM, Riddell C, Chandran V, Eder L, Ghanem A, Ziouzina O, Taghavi-Zadeh S, Ibañez D, Gladman DD. Systemic lupus erythematosus disease activity index 2000 responder index-50: a reliable index for measuring improvement in disease activity. The Journal of Rheumatology. 38: 868-73. PMID 21324961 DOI: 10.3899/Jrheum.101080 |
0.652 |
|
| 2011 |
Reich HN, Gladman DD, Urowitz MB, Bargman JM, Hladunewich MA, Lou W, Fan SC, Su J, Herzenberg AM, Cattran DC, Wither J, Landolt-Marticorena C, Scholey JW, Fortin PR. Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus. Kidney International. 79: 914-20. PMID 21248713 DOI: 10.1038/Ki.2010.525 |
0.451 |
|
| 2011 |
Landolt-Marticorena C, Wither R, Reich H, Herzenberg A, Scholey J, Gladman DD, Urowitz MB, Fortin PR, Wither J. Increased expression of B cell activation factor supports the abnormal expansion of transitional B cells in systemic lupus erythematosus. The Journal of Rheumatology. 38: 642-51. PMID 21239754 DOI: 10.3899/Jrheum.100214 |
0.326 |
|
| 2011 |
Touma Z, Urowitz MB, Ibañez D, Gladman DD. SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation. Lupus. 20: 67-70. PMID 21233149 DOI: 10.1177/0961203310385163 |
0.561 |
|
| 2011 |
Zhang W, Aghdassi E, Reich HN, Su J, Lou W, Landolt-Marticorena C, Gladman DD, Urowitz MB, Scholey J, Fortin PR. Glomerular filtration rate predicts arterial events in women with systemic lupus erythematosus. Rheumatology (Oxford, England). 50: 799-805. PMID 21156670 DOI: 10.1093/Rheumatology/Keq383 |
0.388 |
|
| 2011 |
Ruperto N, Hanrahan LM, Alarcón GS, Belmont HM, Brey RL, Brunetta P, Buyon JP, Costner MI, Cronin ME, Dooley MA, Filocamo G, Fiorentino D, Fortin PR, Franks AG, Gilkeson G, ... ... Urowitz M, et al. International consensus for a definition of disease flare in lupus. Lupus. 20: 453-62. PMID 21148601 DOI: 10.1177/0961203310388445 |
0.38 |
|
| 2011 |
Touma Z, Gladman DD, Ibañez D, Urowitz MB. Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50. The Journal of Rheumatology. 38: 275-84. PMID 21123323 DOI: 10.3899/Jrheum.100724 |
0.642 |
|
| 2011 |
Nikpour M, Urowitz MB, Ibañez D, Gladman DD. Relationship between cardiac symptoms, myocardial perfusion defects and coronary angiography findings in systemic lupus erythematosus. Lupus. 20: 299-304. PMID 21078763 DOI: 10.1177/0961203310381512 |
0.558 |
|
| 2011 |
Bernatsky S, Peschken C, Fortin PR, Pineau CA, Pineau CA, Urowitz MB, Gladman DD, Pope JE, Hudson M, Zummer M, Smith CD, Arbillaga HO, Clarke AE. Medication use in systemic lupus erythematosus. The Journal of Rheumatology. 38: 271-4. PMID 21078722 DOI: 10.3899/Jrheum.100414 |
0.426 |
|
| 2011 |
Ibañez D, Gladman DD, Touma Z, Nikpour M, Urowitz MB. Optimal frequency of visits for patients with systemic lupus erythematosus to measure disease activity over time. The Journal of Rheumatology. 38: 60-3. PMID 21078718 DOI: 10.3899/Jrheum.100575 |
0.718 |
|
| 2011 |
Touma Z, Gladman DD, Urowitz MB, Beyene J, Uleryk EM, Shah PS. Mycophenolate mofetil for induction treatment of lupus nephritis: A systematic review and metaanalysis Journal of Rheumatology. 38: 69-78. PMID 20952473 DOI: 10.3899/Jrheum.100130 |
0.559 |
|
| 2011 |
Hanly JG, Urowitz MB, Su L, Romero-Diaz J. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus (Annals of the Rheumatic Diseases (2011) 70, (1726-1732)) Annals of the Rheumatic Diseases. 70: 2240. DOI: 10.1136/ard.2010.148502corr1 |
0.33 |
|
| 2011 |
Venner A, Ibanez D, Cheung J, Wong S, Grossi L, Gladman D, Urowitz M, MacKinnon A, Blasutig I, Yip P. The performance of three anti-dsDNA immunoassays and their correlation with disease activity in systemic lupus erythematosus patients Clinical Biochemistry. 44: 1184. DOI: 10.1016/J.Clinbiochem.2011.06.068 |
0.487 |
|
| 2010 |
Touma Z, Gladman DD, Tulloch-Reid D, Toloza SM, Ibañez D, Fortin PR, Urowitz MB. Burden of autoantibodies and association with disease activity and damage in systemic lupus erythematosus. Clinical and Experimental Rheumatology. 28: 525-31. PMID 20659409 |
0.593 |
|
| 2010 |
Steiman AJ, Gladman DD, Ibañez D, Urowitz MB. Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome. The Journal of Rheumatology. 37: 1822-7. PMID 20595281 DOI: 10.3899/Jrheum.100007 |
0.459 |
|
| 2010 |
Nikpour M, Gladman DD, Ibanez D, Harvey PJ, Urowitz MB. Variability over time and correlates of cholesterol and blood pressure in systemic lupus erythematosus: a longitudinal cohort study. Arthritis Research & Therapy. 12: R125. PMID 20591138 DOI: 10.1186/Ar3063 |
0.604 |
|
| 2010 |
Urowitz MB, Gladman D, Ibañez D, Bae SC, Sanchez-Guerrero J, Gordon C, Clarke A, Bernatsky S, Fortin PR, Hanly JG, Wallace DJ, Isenberg D, Rahman A, Alarcón GS, Merrill JT, et al. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care & Research. 62: 881-7. PMID 20535799 DOI: 10.1002/Acr.20122 |
0.426 |
|
| 2010 |
Zhu LJ, Landolt-Marticorena C, Li T, Yang X, Yu XQ, Gladman DD, Urowitz MB, Fortin PR, Wither JE. Altered expression of TNF-alpha signaling pathway proteins in systemic lupus erythematosus. The Journal of Rheumatology. 37: 1658-66. PMID 20516030 DOI: 10.3899/Jrheum.091123 |
0.352 |
|
| 2010 |
Yip J, Aghdassi E, Su J, Lou W, Reich H, Bargman J, Scholey J, Gladman DD, Urowitz MB, Fortin PR. Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus. The Journal of Rheumatology. 37: 1667-72. PMID 20516026 DOI: 10.3899/Jrheum.091028 |
0.483 |
|
| 2010 |
Jung H, Bobba R, Su J, Shariati-Sarabi Z, Gladman DD, Urowitz M, Lou W, Fortin PR. The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus. Arthritis and Rheumatism. 62: 863-8. PMID 20131232 DOI: 10.1002/Art.27289 |
0.41 |
|
| 2010 |
Mittoo S, Gelber AC, Hitchon CA, Silverman ED, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman DD, Urowitz MB, Zummer M, Clarke AE, Bernatsky S, Hudson M, et al. Clinical and serologic factors associated with lupus pleuritis. The Journal of Rheumatology. 37: 747-53. PMID 20110526 DOI: 10.3899/Jrheum.090249 |
0.437 |
|
| 2010 |
Aghdassi E, Morrison S, Landolt-Marticorena C, Su J, Pineau CA, Gladman D, Urowitz M, Pope J, Peschken C, Dacosta D, Wither J, Fortin PR. The use of micronutrient supplements is not associated with better quality of life and disease activity in Canadian patients with systemic lupus erythematosus. The Journal of Rheumatology. 37: 87-90. PMID 19955051 DOI: 10.3899/Jrheum.090761 |
0.417 |
|
| 2010 |
Touma Z, Urowitz MB, Gladman DD. SLEDAI-2K for a 30-day window. Lupus. 19: 49-51. PMID 19910390 DOI: 10.1177/0961203309346505 |
0.571 |
|
| 2010 |
Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Wallace DJ, Clarke A, Bernatsky S, Isenberg D, Rahman A, Alarcón GS, Gladman DD, Fortin PR, Sanchez-Guerrero J, Romero-Diaz J, et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 69: 529-35. PMID 19359262 DOI: 10.1136/Ard.2008.106351 |
0.475 |
|
| 2009 |
Goldberg RJ, Urowitz MB, Ibañez D, Nikpour M, Gladman DD. Risk factors for development of coronary artery disease in women with systemic lupus erythematosus. The Journal of Rheumatology. 36: 2454-61. PMID 19833754 DOI: 10.3899/Jrheum.090011 |
0.616 |
|
| 2009 |
Nikpour M, Gladman DD, Ibañez D, Urowitz MB. Variability and correlates of high sensitivity C-reactive protein in systemic lupus erythematosus. Lupus. 18: 966-73. PMID 19762397 DOI: 10.1177/0961203309105130 |
0.627 |
|
| 2009 |
Nikpour M, Urowitz MB, Ibañez D, Gladman DD. Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus. Arthritis and Rheumatism. 61: 1152-8. PMID 19714602 DOI: 10.1002/Art.24741 |
0.642 |
|
| 2009 |
Nikpour M, Urowitz MB, Gladman DD. Epidemiology of atherosclerosis in systemic lupus erythematosus. Current Rheumatology Reports. 11: 248-54. PMID 19691927 DOI: 10.1007/S11926-009-0035-Z |
0.577 |
|
| 2009 |
Peschken CA, Katz SJ, Silverman E, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga HO, Gladman DD, Urowitz M, Zummer M, Clarke A, Bernatsky S, Hudson M. The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort. The Journal of Rheumatology. 36: 1200-8. PMID 19369456 DOI: 10.3899/Jrheum.080912 |
0.428 |
|
| 2009 |
Hochman J, Urowitz MB, Ibañz D, Gladman DD. Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease Lupus. 18: 313-317. PMID 19276299 DOI: 10.1177/0961203308097475 |
0.433 |
|
| 2009 |
Nikpour M, Gladman DD, Ibañez D, Bruce IN, Burns RJ, Urowitz MB. Myocardial perfusion imaging in assessing risk of coronary events in patients with systemic lupus erythematosus. The Journal of Rheumatology. 36: 288-94. PMID 19208561 DOI: 10.3899/Jrheum.080776 |
0.579 |
|
| 2009 |
Toloza S, Pellett F, Chandran V, Ibanez D, Urowitz M, Gladman D. Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus. Lupus. 17: 793-8. PMID 18755860 DOI: 10.1177/0961203308089443 |
0.339 |
|
| 2008 |
Isenberg D, Gordon C, Merrill J, Urowitz M. New therapies in systemic lupus erythematosus – trials, troubles and tribulations…. working towards a solution Lupus. 17: 967-970. PMID 18852218 DOI: 10.1177/0961203308095139 |
0.341 |
|
| 2008 |
Urowitz MB, Gladman DD, Tom BD, Ibañez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. The Journal of Rheumatology. 35: 2152-8. PMID 18793004 DOI: 10.3899/Jrheum.080214 |
0.434 |
|
| 2008 |
Urowitz MB, Gladman DD. The SLICC inception cohort for atherosclerosis. Current Rheumatology Reports. 10: 281-5. PMID 18662507 DOI: 10.1007/S11926-008-0045-2 |
0.487 |
|
| 2008 |
Urowitz MB, Gladman DD, MacKinnon A, Ibañez D, Bruto V, Rovet J, Silverman E. Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus. Lupus. 17: 555-60. PMID 18539709 DOI: 10.1177/0961203308089326 |
0.344 |
|
| 2008 |
Petri M, Kasitanon N, Lee SS, Link K, Magder L, Bae SC, Hanly JG, Isenberg DA, Nived O, Sturfelt G, van Vollenhoven R, Wallace DJ, Alarcón GS, Adu D, Avila-Casado C, ... ... Urowitz MB, et al. Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis and Rheumatism. 58: 1784-8. PMID 18512819 DOI: 10.1002/Art.23456 |
0.325 |
|
| 2008 |
Petri M, Kasitanon N, Singh S, Link K, Magder L, Bae SC, Hanly JG, Nived O, Sturfelt G, van Vollenhoven R, Wallace DJ, Alarcón GS, Adu D, Avila-Casado C, Bernatsky SR, ... ... Urowitz MB, et al. Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. Arthritis and Rheumatism. 58: 1789-95. PMID 18512814 DOI: 10.1002/Art.23802 |
0.316 |
|
| 2008 |
Hanly JG, Urowitz MB, Su L, Sanchez-Guerrero J, Bae SC, Gordon C, Wallace DJ, Isenberg D, Alarcón GS, Merrill JT, Clarke A, Bernatsky S, Dooley MA, Fortin PR, Gladman D, et al. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis and Rheumatism. 59: 721-9. PMID 18438902 DOI: 10.1002/Art.23566 |
0.42 |
|
| 2008 |
Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC, Isenberg D, Dooley MA, Clarke A, Bernatsky S, Gladman D, Fortin PR, Manzi S, Steinsson K, Bruce IN, et al. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis and Rheumatism. 58: 843-53. PMID 18311802 DOI: 10.1002/Art.23218 |
0.396 |
|
| 2008 |
Urowitz MB, Gladman D, Ibañez D, Fortin P, Sanchez-Guerrero J, Bae S, Clarke A, Bernatsky S, Gordon C, Hanly J, Wallace D, Isenberg D, Ginzler E, Merrill J, Alarcón GS, et al. Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis and Rheumatism. 59: 176-80. PMID 18240193 DOI: 10.1002/Art.23353 |
0.431 |
|
| 2008 |
Kuriya B, Gladman DD, Ibañez D, Urowitz MB. Quality of life over time in patients with systemic lupus erythematosus. Arthritis and Rheumatism. 59: 181-5. PMID 18240183 DOI: 10.1002/Art.23339 |
0.419 |
|
| 2008 |
Chang NH, McKenzie T, Bonventi G, Landolt-Marticorena C, Fortin PR, Gladman D, Urowitz M, Wither JE. Expanded population of activated antigen-engaged cells within the naive B cell compartment of patients with systemic lupus erythematosus. Journal of Immunology (Baltimore, Md. : 1950). 180: 1276-84. PMID 18178868 DOI: 10.4049/Jimmunol.180.2.1276 |
0.301 |
|
| 2008 |
Nikpour M, Dempsey AA, Urowitz MB, Gladman DD, Barnes DA. Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus. Annals of the Rheumatic Diseases. 67: 1069-75. PMID 18063674 DOI: 10.1136/Ard.2007.074765 |
0.553 |
|
| 2007 |
Urowitz MB, Gladman DD. Atherosclerosis and lupus - The SLICC study Lupus. 16: 925-928. PMID 18042585 DOI: 10.1177/0961203307085259 |
0.431 |
|
| 2007 |
Urowitz MB, Gladman D, Ibañez D, Fortin P, Sanchez-Guerrero J, Bae S, Clarke A, Bernatsky S, Gordon C, Hanly J, Wallace D, Isenberg D, Ginzler E, Merrill J, Alarcon G, et al. Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus. 16: 731-5. PMID 17728367 DOI: 10.1177/0961203307081113 |
0.458 |
|
| 2007 |
Toloza S, Urowitz MB, Gladman DD. Should all patients with systemic lupus erythematosus receive cardioprotection with statins? Nature Clinical Practice. Rheumatology. 3: 536-7. PMID 17700557 DOI: 10.1038/Ncprheum0593 |
0.505 |
|
| 2007 |
Ali YM, Urowitz MB, Ibanez D, Gladman DD. Monoclonal gammopathy in systemic lupus erythematosus. Lupus. 16: 426-9. PMID 17664233 DOI: 10.1177/0961203307079045 |
0.482 |
|
| 2007 |
Pellett F, Siannis F, Vukin I, Lee P, Urowitz MB, Gladman DD. KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma. Tissue Antigens. 106-8. PMID 17445179 DOI: 10.1111/J.1399-0039.2006.762_6.X |
0.412 |
|
| 2007 |
Prasad R, Ibanez D, Gladman D, Urowitz MB. The role of non-corticosteroid related factors in osteonecrosis (ON) in systemic lupus erythematosus: A nested case-control study of inception patients Lupus. 16: 157-162. PMID 17432099 DOI: 10.1177/0961203306075771 |
0.409 |
|
| 2007 |
Bernatsky S, Clarke A, Gladman DD, Urowitz M, Fortin PR, Barr SG, Senécal JL, Zummer M, Edworthy S, Sibley J, Pope J, Ensworth S, Ramsey-Goldman R, Hanly JG. Mortality related to cerebrovascular disease in systemic lupus erythematosus. Lupus. 15: 835-9. PMID 17211987 DOI: 10.1177/0961203306073133 |
0.307 |
|
| 2007 |
Hanly JG, Urowitz MB, Sanchez-Guerrero J, Bae SC, Gordon C, Wallace DJ, Isenberg D, Alarcón GS, Clarke A, Bernatsky S, Merrill JT, Petri M, Dooley MA, Gladman D, Fortin PR, et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis and Rheumatism. 56: 265-73. PMID 17195230 DOI: 10.1002/Art.22305 |
0.473 |
|
| 2007 |
Ibañez D, Gladman D, Urowitz M. Summarizing disease features over time: II. Variability measures of SLEDAI-2K Journal of Rheumatology. 34: 336-340. PMID 17183620 |
0.308 |
|
| 2007 |
Urowitz MB, Ibañez D, Gladman DD. Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. The Journal of Rheumatology. 34: 70-5. PMID 17117488 |
0.326 |
|
| 2007 |
Urowitz MB. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with SLE Future Rheumatology. 2: 139-141. DOI: 10.2217/17460816.2.2.139 |
0.437 |
|
| 2006 |
Urowitz MB, Ibañez D, Jerome D, Gladman DD. The effect of menopause on disease activity in systemic lupus erythematosus. The Journal of Rheumatology. 33: 2192-8. PMID 16981295 |
0.371 |
|
| 2006 |
Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, et al. Mortality in systemic lupus erythematosus. Arthritis and Rheumatism. 54: 2550-7. PMID 16868977 DOI: 10.1002/Art.21955 |
0.401 |
|
| 2006 |
Tisseverasinghe A, Lim S, Greenwood C, Urowitz M, Gladman D, Fortin PR. Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus. Arthritis and Rheumatism. 54: 2211-9. PMID 16802357 DOI: 10.1002/Art.21929 |
0.4 |
|
| 2006 |
Prasad R, Ibañez D, Gladman D, Urowitz M. Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus Lupus. 15: 285-291. PMID 16761503 DOI: 10.1191/0961203306Lu2302Oa |
0.363 |
|
| 2006 |
Urowitz MB, Gladman DD, Ibanez D, Berliner Y. Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: A quality improvement study Annals of the Rheumatic Diseases. 65: 115-117. PMID 16344496 DOI: 10.1136/Ard.2005.038802 |
0.436 |
|
| 2005 |
Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin P, Gordon C, Barr S, Edworthy S, Bae SC, Petri M, Sibley J, Isenberg D, et al. Race/ethnicity and cancer occurrence in systemic lupus erythematosus. Arthritis and Rheumatism. 53: 781-4. PMID 16208671 DOI: 10.1002/Art.21458 |
0.371 |
|
| 2005 |
Bernatsky S, Ramsey-Goldman R, Rajan R, Boivin JF, Joseph L, Lachance S, Cournoyer D, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, Edworthy S, Barr S, et al. Non-Hodgkin's lymphoma in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 64: 1507-9. PMID 16162903 DOI: 10.1136/Ard.2004.034504 |
0.4 |
|
| 2005 |
Sarabi ZS, Chang E, Bobba R, Ibanez D, Gladman D, Urowitz M, Fortin PR. Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus. Arthritis Care and Research. 53: 609-612. PMID 16082635 DOI: 10.1002/Art.21314 |
0.446 |
|
| 2005 |
Urowitz MB, Feletar M, Bruce IN, Ibañez D, Gladman DD. Prolonged remission in systemic lupus erythematosus. The Journal of Rheumatology. 32: 1467-72. PMID 16078321 |
0.375 |
|
| 2005 |
Nikpour M, Urowitz MB, Gladman DD. Premature atherosclerosis in systemic lupus erythematosus. Rheumatic Diseases Clinics of North America. 31: 329-54, vii-viii. PMID 15922149 DOI: 10.1016/j.rdc.2005.01.001 |
0.586 |
|
| 2005 |
Urowitz MB, Gladman DD. Contributions of observational cohort studies in systemic lupus erythematosus: the university of toronto lupus clinic experience. Rheumatic Diseases Clinics of North America. 31: 211-21, v. PMID 15922142 DOI: 10.1016/J.Rdc.2005.01.008 |
0.48 |
|
| 2005 |
Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, Petri M, Edworthy S, Barr S, Gordon C, Bae SC, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis and Rheumatism. 52: 1481-90. PMID 15880596 DOI: 10.1002/Art.21029 |
0.437 |
|
| 2005 |
Ibañez D, Gladman DD, Urowitz MB. Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE. The Journal of Rheumatology. 32: 824-7. PMID 15868616 |
0.377 |
|
| 2005 |
Benk V, Al-Herz A, Gladman D, Urowitz M, Fortin PR. Role of radiation therapy in patients with a diagnosis of both systemic lupus erythematosus and cancer. Arthritis and Rheumatism. 53: 67-72. PMID 15696566 DOI: 10.1002/Art.20912 |
0.333 |
|
| 2005 |
Johnson SR, Gladman DD, Urowitz MB, Ibañez D, Granton JT. Pulmonary hypertension in systemic lupus. Lupus. 13: 506-9. PMID 15352421 DOI: 10.1191/0961203303Lu1051Oa |
0.4 |
|
| 2004 |
Johnson SR, Harvey PJ, Floras JS, Iwanochko M, Ibanez D, Gladman DD, Urowitz M. Impaired brachial artery endothelium dependent flow mediated dilation in systemic lupus erythematosus: preliminary observations. Lupus. 13: 590-3. PMID 15462488 DOI: 10.1191/0961203304Lu1072Oa |
0.34 |
|
| 2004 |
Abu-Shakra M, Gladman DD, Urowitz MB. Mortality studies in SLE: how far can we improve survival of patients with SLE. Autoimmunity Reviews. 3: 418-20. PMID 15351308 DOI: 10.1016/J.Autrev.2004.07.003 |
0.365 |
|
| 2004 |
Pineau CA, Urowitz MB, Fortin PJ, Ibanez D, Gladman DD. Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density. Lupus. 13: 436-41. PMID 15303570 DOI: 10.1191/0961203303Lu1036Oa |
0.362 |
|
| 2003 |
Bruce IN, Urowitz MB, Gladman DD, Ibañez D, Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis and Rheumatism. 48: 3159-67. PMID 14613278 DOI: 10.1002/Art.11296 |
0.374 |
|
| 2003 |
Gladman DD, Hirani N, Ibañez D, Urowitz MB. Clinically active serologically quiescent systemic lupus erythematosus. The Journal of Rheumatology. 30: 1960-2. PMID 12966598 |
0.382 |
|
| 2003 |
Gladman DD, Urowitz MB, Rahman P, Ibañez D, Tam LS. Accrual of organ damage over time in patients with systemic lupus erythematosus. The Journal of Rheumatology. 30: 1955-9. PMID 12966597 |
0.352 |
|
| 2003 |
Feletar M, Ibañez D, Urowitz MB, Gladman DD. The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: what has been changed? Arthritis and Rheumatism. 48: 2067-9. PMID 12847702 DOI: 10.1002/Art.11167 |
0.395 |
|
| 2003 |
Brunner HI, Feldman BM, Urowitz MB, Gladman DD. Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement. The Journal of Rheumatology. 30: 292-7. PMID 12563683 |
0.369 |
|
| 2003 |
Farewell VT, Lawless JF, Gladman DD, Urowitz MB. Tracing studies and analysis of the effect of loss to follow-up on mortality estimation from patient registry data Journal of the Royal Statistical Society. Series C: Applied Statistics. 52: 445-456. DOI: 10.1111/1467-9876.00416 |
0.364 |
|
| 2002 |
Gladman DD, Hussain F, Ibañez D, Urowitz MB. The nature and outcome of infection in systemic lupus erythematosus Lupus. 11: 234-239. PMID 12043887 DOI: 10.1191/0961203302Lu170Oa |
0.353 |
|
| 2002 |
Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. The Journal of Rheumatology. 29: 288-91. PMID 11838846 |
0.347 |
|
| 2001 |
Rahman P, Gladman DD, Ibanez D, Urowitz MB. Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosus Lupus. 10: 418-423. PMID 11434577 DOI: 10.1191/096120301678646164 |
0.335 |
|
| 2001 |
Rahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus Lupus. 10: 93-96. PMID 11237132 DOI: 10.1191/096120301670679959 |
0.391 |
|
| 2000 |
Bruce IN, Gladman DD, Urowitz MB. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: The role of patient nonadherence Arthritis Care and Research. 13: 406-408. PMID 14635317 DOI: 10.1002/1529-0131(200012)13:6<406::Aid-Art11>3.0.Co;2-2 |
0.44 |
|
| 2000 |
Rahman P, Aguero S, Gladman DD, Hallett D, Urowitz MB. Vascular events in hypertensive patients with systemic lupus erythematosus Lupus. 9: 672-675. PMID 11199921 DOI: 10.1191/096120300669204787 |
0.384 |
|
| 2000 |
Urowitz M, Gladman D, Bruce I. Atherosclerosis and systemic lupus erythematosus Current Rheumatology Reports. 2: 19-23. PMID 11123035 DOI: 10.1007/S11926-996-0064-9 |
0.462 |
|
| 2000 |
Cook RJ, Gladman DD, Pericak D, Urowitz MB. Prediction of short term mortality in systemic lupus erythematosus with term dependent measures of disease activity Journal of Rheumatology. 27: 1892-1895. PMID 10955329 |
0.361 |
|
| 2000 |
Urowitz MB, Gladman DD. Accelerated atheroma in lupus - Background Lupus. 9: 161-165. PMID 10805481 DOI: 10.1191/096120300678828271 |
0.432 |
|
| 2000 |
Urowitz MB, Gladman DD. How to improve morbidity and mortality in systemic lupus erythematosus Rheumatology. 39: 238-244. PMID 10788530 DOI: 10.1093/Rheumatology/39.3.238 |
0.406 |
|
| 2000 |
Bruce IN, Gladman DD, Urowitz MB. Premature atherosclerosis in systemic lupus erythematosus. Rheumatic Diseases Clinics of North America. 26: 257-78. PMID 10768212 DOI: 10.1016/S0889-857X(05)70138-1 |
0.441 |
|
| 2000 |
Gladman DD, Urowitz MB, Kagal A, Hallett D. Accurately describing changes in disease activity in systemic lupus erythematosus Journal of Rheumatology. 27: 377-379. PMID 10685800 |
0.38 |
|
| 2000 |
Bruce IN, Gladman DD, Urowitz MB. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: The role of patient nonadherence Arthritis & Rheumatism. 13: 406-408. DOI: 10.1002/1529-0131(200012)13:6<406::AID-ART11>3.0.CO;2-2 |
0.359 |
|
| 1999 |
Gladman DD, Urowitz MB. The SLICC/ACR damage index: Progress report and experience in the field Lupus. 8: 632-637. PMID 10568900 DOI: 10.1191/096120399680411335 |
0.361 |
|
| 1999 |
Bruce IN, Urowitz MB, Gladman DD, Hallett DC. Natural history of hypercholesterolemia in systemic lupus erythematosus Journal of Rheumatology. 26: 2137-2143. PMID 10529129 |
0.303 |
|
| 1999 |
Gladman DD, Urowitz MB, Esdaile JM, Hahn BH, Klippel J, Lahita R, Liang MH, Schur P, Petri M, Wallace D. Guidelines for referral and management of systemic lupus erythematosus in adults Arthritis & Rheumatism. 42: 1785-1796. PMID 10513791 DOI: 10.1002/1529-0131(199909)42:9<1785::Aid-Anr1>3.0.Co;2-# |
0.35 |
|
| 1999 |
Gladman DD, Urowitz MB, Darlington GA. Disease expression and class II HLA antigens in systemic lupus erythematosus Lupus. 8: 466-470. PMID 10483016 DOI: 10.1177/096120339900800610 |
0.336 |
|
| 1999 |
Bruce IN, Hallett DC, Gladman DD, Urowitz MB. Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy Journal of Rheumatology. 26: 1490-1494. PMID 10405935 |
0.309 |
|
| 1999 |
Bruce IN, Mak VC, Hallett DC, Gladman DD, Urowitz MB. Factors associated with fatigue in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 58: 379-81. PMID 10340963 DOI: 10.1136/Ard.58.6.379 |
0.465 |
|
| 1998 |
Urowitz MB, Gladman DD. Measures of disease activity and damage in SLE Bailliere's Clinical Rheumatology. 12: 405-413. PMID 9890104 DOI: 10.1016/S0950-3579(98)80027-7 |
0.45 |
|
| 1998 |
Chaudhry-Ahlawalia V, Gladman DD, Urowitz MB, Bogoch E, Farewell VT. Radiographic Reports in Osteonecrosis of the Hip in Systemic Lupus Erythematosus Clinical Orthopaedics and Related Research. 352: 131???136. DOI: 10.1097/00003086-199807000-00016 |
0.36 |
|
| 1997 |
Kreidstein S, Urowitz MB, Gladman DD, Gough J. Hormone replacement therapy in systemic lupus erythematosus Journal of Rheumatology. 24: 2149-2152. PMID 9375875 |
0.361 |
|
| 1997 |
Gladman DD, Urowitz MB, Gough J, MacKinnon A. Fibromyalgia is a major contributor to quality of life in lupus Journal of Rheumatology. 24: 2145-2148. PMID 9375874 |
0.339 |
|
| 1997 |
Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, Hanly JG, Isenberg DA, Kalunian K, Nived O, Petri M, Sanchez-Guerrero J, Snaith M, Sturfelt G. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis and Rheumatism. 40: 809-13. PMID 9153540 DOI: 10.1002/Art.1780400506 |
0.5 |
|
| 1996 |
Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE) Lupus. 5: 190-195. PMID 8803889 DOI: 10.1177/096120339600500305 |
0.372 |
|
| 1996 |
Abu-Shakra M, Gladman DD, Urowitz MB. Malignancy in systemic lupus erythematosus Arthritis and Rheumatism. 39: 1050-1054. PMID 8651970 DOI: 10.1002/Art.1780390625 |
0.391 |
|
| 1996 |
Abu-Shakra M, Urowitz MB, Gladman DD, Ritchie S. The significance of anticardiolipin antibodies in patients with lupus nephritis Lupus. 5: 70-73. PMID 8646230 DOI: 10.1177/096120339600500113 |
0.386 |
|
| 1996 |
Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis and Rheumatism. 39: 363-9. PMID 8607884 DOI: 10.1002/Art.1780390303 |
0.456 |
|
| 1995 |
Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality Journal of Rheumatology. 22: 1265-1270. PMID 7562756 |
0.314 |
|
| 1995 |
Abu-Shakra M, Gladman DD, Urowitz MB, Farewell V. Anticardiolipin antibodies in systemic lupus erythematosus: Clinical and laboratory correlations American Journal of Medicine. 99: 624-628. PMID 7503085 DOI: 10.1016/S0002-9343(99)80249-6 |
0.389 |
|
| 1994 |
Walz LeBlanc BAE, Urowitz MB, Gladman DD. Serologically active, clinically quiescent systemic lupus erythematosus - Longterm followup [3] Journal of Rheumatology. 21: 174-175. PMID 8151579 |
0.337 |
|
| 1994 |
Walz Leblanc BAE, Dagenais P, Urowitz MB, Gladman DD. Methotrexate in systemic lupus erythematosus Journal of Rheumatology. 21: 836-838. PMID 8064722 |
0.348 |
|
| 1994 |
Pauzner R, Urowitz MB, Gladman DD, Gough JM. Prolactin in systemic lupus erythematosus Journal of Rheumatology. 21: 2064-2067. PMID 7869311 |
0.406 |
|
| 1994 |
Walz LeBlanc BAE, Gladman DD, Urowitz MB. Serologically active clinically quiescent systemic lupus erythematosus predictors of clinical flares Journal of Rheumatology. 21: 2239-2241. PMID 7699623 |
0.327 |
|
| 1993 |
Urowitz MB. Is 'aggressive' therapy necessary for systemic lupus erythematosus? Rheumatic Disease Clinics of North America. 19: 263-270. PMID 8356259 |
0.341 |
|
| 1993 |
Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J. Lupus and pregnancy studies. Arthritis and Rheumatism. 36: 1392-7. PMID 8216399 DOI: 10.1002/Art.1780361011 |
0.368 |
|
| 1992 |
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, Austin HA, Bell DA, Bloch DA, Corey PN, Decker JL, Esdaile J, Fries JF, Ginzler EM, Goldsmith CH, Hochberg MC, et al. Derivation of the SLEDAI: A disease activity index for lupus patients Arthritis and Rheumatism. 35: 630-640. PMID 1599520 DOI: 10.1002/Art.1780350606 |
0.444 |
|
| 1992 |
Sasson Z, Rasooly Y, Chow CW, Marshall S, Urowitz MB. Impairment of left ventricular diastolic function in systemic lupus erythematosus. The American Journal of Cardiology. 69: 1629-34. PMID 1598881 DOI: 10.1016/0002-9149(92)90715-B |
0.412 |
|
| 1992 |
McDonald J, Stewart J, Urowitz MB, Gladman DD. Peripheral vascular disease in patients with systemic lupus erythematosus Annals of the Rheumatic Diseases. 51: 56-60. PMID 1540039 DOI: 10.1136/Ard.51.1.56 |
0.494 |
|
| 1992 |
Gladman DD, Urowitz MB. Assessment of disease activity in lupus Transfusion Science. 13: 129-134. DOI: 10.1016/0955-3886(92)90163-B |
0.463 |
|
| 1991 |
Levy M, Buskila D, Gladman DD, Urowitz MB, Koren G. Pregnancy outcome following first trimester exposure to chloroquine. American Journal of Perinatology. 8: 174-8. PMID 2029276 DOI: 10.1055/S-2007-999371 |
0.302 |
|
| 1990 |
Urowitz MB, Lee P. The risks of antimalarial retinopathy, azathioprine lymphoma and methotrexate hepatotoxicity during the treatment of rheumatoid arthritis Bailliere's Clinical Rheumatology. 4: 193-206. PMID 2032296 DOI: 10.1016/S0950-3579(05)80017-2 |
0.326 |
|
| 1989 |
Ganczarczyk L, Urowitz MB, Gladman DD. "Latent lupus". The Journal of Rheumatology. 16: 475-8. PMID 2746587 |
0.378 |
|
| 1989 |
Gladman DD, Urowitz MB, Cole E, Ritchie S, Chang CH, Churg J. Kidney biopsy in SLE. I. A clinical-morphologic evaluation. Qjm: An International Journal of Medicine. 73: 1125-1133. DOI: 10.1093/Oxfordjournals.Qjmed.A068402 |
0.368 |
|
| 1988 |
Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M. Lupus retinopathy. Patterns, associations, and prognosis Arthritis and Rheumatism. 31: 1105-1110. PMID 3422014 DOI: 10.1002/Art.1780310904 |
0.439 |
|
| 1988 |
Stafford-Brady FJ, Gladman DD, Urowitz MB. Successful pregnancy in systemic lupus erythematosus with an untreated lupus anticoagulant Archives of Internal Medicine. 148: 1647-1648. PMID 3132903 DOI: 10.1001/Archinte.1988.00380070129031 |
0.338 |
|
| 1988 |
Hanly JG, Gladman DD, Rose TH, Laskin CA, Urowitz MB. Lupus pregnancy. A prospective study of placental changes. Arthritis and Rheumatism. 31: 358-66. PMID 3128986 DOI: 10.1002/Art.1780310307 |
0.388 |
|
| 1987 |
Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus Journal of Rheumatology. 14: 223-226. PMID 3612650 |
0.367 |
|
| 1987 |
Futran J, Shore A, Urowitz MB, Grossman H. Subdural hematoma in systemic lupus erythematosus: Report and review of the literature Journal of Rheumatology. 14: 378-381. PMID 3599010 |
0.32 |
|
| 1986 |
Hanly JG, Urowitz MB. Tendon rupture in systemic lupus erythematosus Annals of the Rheumatic Diseases. 45: 349. PMID 3707223 |
0.323 |
|
| 1985 |
Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. The Quarterly Journal of Medicine. 55: 87-98. PMID 4011845 DOI: 10.1093/Oxfordjournals.Qjmed.A067857 |
0.471 |
|
| 1984 |
Rubin L, Urowitz MB, Pruzanski W. Systemic lupus erythematosus with paraproteinemia Arthritis and Rheumatism. 27: 638-644. PMID 6610425 |
0.306 |
|
| 1984 |
Miller MH, Urowitz MB, Gladman DD, Blendis LM. The liver in systemic lupus erythematosus Quarterly Journal of Medicine. 53: 401-409. PMID 6484120 DOI: 10.1093/Oxfordjournals.Qjmed.A067812 |
0.389 |
|
| 1984 |
Miller MH, Urowitz MB, Gladman DD, Tozman ECS. Chronic Adhesive Lupus Serositis as a Complication of Systemic Lupus Erythematosus: Refractory Chest Pain and Small-Bowel Obstruction Archives of Internal Medicine. 144: 1863-1864. PMID 6477010 DOI: 10.1001/Archinte.1984.00350210193033 |
0.365 |
|
| 1984 |
Ehrenfeld M, Urowitz MB, Platts ME. Selective C4 deficiency, systemic lupus erythematosus and Whipple's disease Annals of the Rheumatic Diseases. 43: 91-94. PMID 6198977 |
0.311 |
|
| 1983 |
Baron M, Feiglin D, Hyland R, Urowitz MB, Shiff B. 67Gallium lung scans in progressive systemic sclerosis. Arthritis and Rheumatism. 26: 969-74. PMID 6882491 DOI: 10.1002/Art.1780260805 |
0.354 |
|
| 1983 |
Gladman DD, Urowitz MB, Tozman EC, Glynn MFX. Haemostatic abnormalities in systemic lupus erythematosus Quarterly Journal of Medicine. 52: 424-433. PMID 6647751 DOI: 10.1093/Oxfordjournals.Qjmed.A067771 |
0.427 |
|
| 1983 |
Carette S, Urowitz MB. Systemic lupus erythematosus and diffuse soft tissue calcifications International Journal of Dermatology. 22: 416-418. PMID 6629605 DOI: 10.1111/J.1365-4362.1983.Tb02161.X |
0.38 |
|
| 1983 |
Miller MH, Urowitz MB, Gladman DD. The significance of thrombocytopenia in systemic lupus erythematosus Arthritis and Rheumatism. 26: 1181-1186. PMID 6626277 DOI: 10.1002/art.1780261002 |
0.405 |
|
| 1982 |
Thorne C, Urowitz MB. Long-term outcome in Felty's syndrome Annals of the Rheumatic Diseases. 41: 486-489. PMID 7125718 DOI: 10.1136/Ard.41.5.486 |
0.302 |
|
| 1982 |
Tozman ECS, Urowitz MB, Gladman DD. Prolonged complete remission in previously severe SLE Annals of the Rheumatic Diseases. 41: 39-40. PMID 7065728 DOI: 10.1136/ard.41.1.39 |
0.345 |
|
| 1980 |
Gladman DD, Urowitz MB. Venous syndromes and pulmonary embolism in systemic lupus erythematosus Annals of the Rheumatic Diseases. 39: 340-343. PMID 7436559 |
0.333 |
|
| 1979 |
Littlejohn GO, Urowitz MB. Cimetidine, lupus erythematosus, and granulocytopenia Annals of Internal Medicine. 91: 317-318. PMID 464481 |
0.337 |
|
| 1979 |
Tenenbaum J, Urowitz MB, Keystone EC, Dwosh IL, Curtis JE. Leucapheresis in severe rheumatoid arthritis. Annals of the Rheumatic Diseases. 38: 40-4. PMID 434945 DOI: 10.1136/Ard.38.1.40 |
0.318 |
|
| 1979 |
Gladman DD, Urowitz MB, Keystone EC. Serologically active clinically quiescent systemic lupus erythematosus. A discordance between clinical and serologic features The American Journal of Medicine. 66: 210-215. PMID 218447 DOI: 10.1016/0002-9343(79)90529-1 |
0.461 |
|
| 1978 |
Urowitz MB, Gladman DD, Chalmers A, Ogryzlo MA. Nail lesions in systemic lupus erythematosus Journal of Rheumatology. 5: 441-447. PMID 739493 |
0.323 |
|
| 1978 |
Pruzanski W, Armstrong M, Urowitz MB. Heterogeneity of cold- and warm-reacting cytotoxins against lymphocytes, granulocytes, and monocytes in rheumatic diseases Clinical Immunology and Immunopathology. 11: 142-156. PMID 737913 DOI: 10.1016/0090-1229(78)90039-9 |
0.354 |
|
| 1978 |
de Bosset P, Gordon DA, Smythe HA, Urowitz MB, Koehler BE, Singal DP. Comparison of osteitis condensans ilii and ankylosing spondylitis in female patients: clinical, radiological and HLA typing characteristics. Journal of Chronic Diseases. 31: 171-81. PMID 670538 DOI: 10.1016/0021-9681(78)90032-2 |
0.377 |
|
| 1978 |
Gladman DD, Chalmers A, Urowitz MB. Systemic lupus erythematosus with negative LE cells and antinuclear factor Journal of Rheumatology. 5: 142-147. PMID 78982 |
0.325 |
|
| 1977 |
Urowitz MB. SLE subsets--divide and conquer Journal of Rheumatology. 4: 332-333. PMID 604472 |
0.308 |
|
| 1977 |
Lee P, Urowitz MB, Bookman AAM, Koehler BE, Smythe HA, Gordon DA, Ogryzlo MA. Systemic Lupus ErythematosusA REVIEW OF 110 CASES WITH REFERENCE TO NEPHRITIS, THE NERVOUS SYSTEM, INFECTIONS, ASEPTIC NECROSIS AND PROGNOSIS Qjm: An International Journal of Medicine. 46: 1-32. DOI: 10.1093/Oxfordjournals.Qjmed.A067490 |
0.445 |
|
| 1976 |
Gladman DD, Gordon DA, Urowitz MB, Levy HL. Pericardial fluid analysis in scleroderma (systemic sclerosis) The American Journal of Medicine. 60: 1064-1068. PMID 937352 DOI: 10.1016/0002-9343(76)90582-9 |
0.41 |
|
| 1975 |
Hunter T, Urowitz MB, Gordon DA, Smythe HA, Ogryzlo MA. Azathioprine in rheumatoid arthritis: a long-term follow-up study. Arthritis and Rheumatism. 18: 15-20. PMID 1090297 DOI: 10.1002/Art.1780180103 |
0.365 |
|
| 1973 |
Urowitz MB, Gordon DA, Broder I. Studies into the occurrence of soluble antigen-antibody complexes in disease. V. Second assessment of correlation between the rheumatoid biologically active factor (RBAF) and the clinical features of rheumatoid arthritis Arthritis and Rheumatism. 16: 225-230. PMID 4123762 DOI: 10.1002/Art.1780160214 |
0.399 |
|
| Show low-probability matches. |